submitted by dr saima rubab khan dbc-02123003
TRANSCRIPT
IMPLICATION OF PROGNOSTIC VARIABLES AND THEIR POTENTIAL ROLES IN THE
DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA (OSCC): A STUDY FROM
LOCAL POPULATION
SUBMITTED BY
DR SAIMA RUBAB KHAN
DBC-02123003
IN PARTIAL FULFILLMENT FOR THE DEGREE OF DOCTOR OF PHILOSOPHY
(PH.D) IN BIOCHEMISTRY
INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY
THE UNIVERSITY OF LAHORE
2012-2017
i
"Bismillah al rahman al rahim"
In the name of Allah the most gracious the most merciful
ii
SUPERVISrORY COMMITTEE
We, the Supervisory Committee, certify that the contents and form of thesis submitted by DR.
SAIMA RUBAB KHAN (REG. # DBC-02123003) have been found satisfactory after receiving
all the evaluation reports (External/Internal) and recommended it for the award of the degree of
Doctor of Philosophy (PhD) in Biochemistry under title “IMPLICATIONS OF PROGNOSTIC
VARIABLES AND THEIR POTENTIAL ROLE IN THE DEVELOPMENT OF ORAL
SQUAMOUS CELL CARCINOMA (OSCC): STUDY FROM LOCAL POPULATION”.
SUPERVISOR: PROF. DR. ARIF MALIK _________________________
Institute of Molecular Biology and Biotechnology (IMBB/
Center for Research in Molecular Medicine (CRiMM)
The University of Lahore.
CO-SUPERVISOR (I): PROF. DR. M. H. QAZI___________________________
Institute of Molecular Biology and Biotechnology (IMBB/
Center for Research in Molecular Medicine (CRiMM)
The University of Lahore.
CO-SUPERVISOR (II): PROF. DR. MURAD KHAN ___________________________
Professor of Biochemistry
ABWA Medical College.
Faisalabad.
MEMBER: MS. RABAIL ALAM (BIOSTATICIAN)__________________
Institute of Molecular Biology and Biotechnology (IMBB/
Center for Research in Molecular Medicine (CRiMM)
The University of Lahore.
iii
EXAMINATION COMMITTEE
The thesis viva DR SAIMA RUBAB KHAN (REG.# DBC-2123003) was held on 17-11-2017
at the Institute of Molecular Biology and Biotechnology/ Center for Research in Molecular
Medicine (CRiMM), The University of Lahore. The Supervisor/Co-Supervisor and the examiner
gave satisfactory remarks on thesis and viva and were approved for the award of the degree of
Doctor of Philosophy (PhD) in Biochemistry under title “IMPLICATIONS OF PROGNOSTIC
VARIABLES AND THEIR POTENTIAL ROLE IN THE DEVELOPMENT OF ORAL
SQUAMOUS CELL CARCINOMA (OSCC): STUDY FROM LOCAL POPULATION”.
______________________________________ ______________________________________
EXTERNAL EXAMINER INTERNAL EXAMINER
PROF. DR. ZAMEER AHMAD PROF. DR. ARIF MALIK
DEPARTMENT OF BIOCHEMISTRY
ALLAMA IQBAL MEDICAL COLLEGE LAHORE INSTITUTE OF MOLECULAR BIOLOGY AND
BIOTECHNOLOGY (IMBB/CENTER FOR
RESEARCH IN MOLECULAR MEDICINE
(CRIMM).
____________________________________________
PROF. DR. M. H. QAZI
DIRECTOR,
INSTITUTE OF MOLECULAR BIOLOGY AND
BIOTECHNOLOGY (IMBB/CENTER FOR
RESEARCH IN MOLECULAR MEDICINE (CRIMM)
iv
ACKNOWLEDGEMENTS
ALL PRAISES FOR ALLAH, WHO GUIDES US FROM DARKNESS TO LIGHT AND HELP
US IN ALL HARDSHIPS, AND ALL MY REVERENCE IS FOR HIS HOLY PROPHET
MOHAMMAD (P.B.U.H) WHO ENABLES US TO RECOGNIZE OUR CREATOR. I AM GRATEFUL
TO THAT SPIRITUAL POWER WHO HELPS ME AT EVERY STAGE OF MY LIFE. GREAT
PERSONALITIES HAVE BROUGHT IMPECCABLE TRANSFORMATION AND AMAZING
CHANGES IN THE USUAL ROUTINES. WHETHER IT IS POLITICS OR ARTS OR SCIENCE,
WHETHER IT IS RELIGIOUS OR PHILOSOPHICAL, WHETHER IT IS BIG OR SMALL, THE
IMPACT MADE BY PEOPLE MADE THEM FAMOUS PERSONALITIES. PROF. DR. ARIF
MALIK “INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY/CENTER FOR
RESEARCH IN MOLECULAR MEDICINE” MY RESPECTED SUPERVISOR; HIS IDEAS HAVE
MANAGED TO COME THROUGH AND HAVE REVOLUTIONIZED THE FACE OF MODERN
SCIENCE. IT IS MY FOREMOST DUTY TO EXPRESS MY HEARTIEST AND SINCEREST
GRATITUDE TO MY RESPECTED CO-SUPERVISOR PROF. DR. M.H. QAZI, DIRECTOR,
INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY FOR THEIR KIND
GUIDANCE DURING MY STUDIES. I AM MUCH OBLIGED TO HIM FOR PRODUCTIVE
GUIDANCE. I ACKNOWLEDGE PROF. DR. SALEEM SHUJA EX-RECTOR OF UNIVERSITY OF
LAHORE, SULAYMAN WAQUAR, SARA ZAHID AND SAEED ISMAIL FOR THEIR HELP IN
THE COMPILATION OF MY WORK. LAST BUT NOT LEAST I OW MY SPECIAL THANKS TO
MY HUSBAND ALI MAQUDDAS KHAN AND MY SONS ALI ABBAS KHAN AND HUSSAIN
ABBAS KHAN FOR THEIR LOVE AND SUPPORT AT EVERY WALK OF MY LIFE.
DR SAIMA RUBAB KHAN
REG.# DBC-02123003
v
DECLARATION OF ORIGINALITY
NAME OF STUDENT: DR. SAIMA RUBAB KHAN
REG.#: (REG.# DBC-02123003)
DECLARATION
1-understand what plagiarism is and I am aware of the University’s policy in this regard.
2-I declare the thesis is my own original work. Where other people’s work has been used (Either from a
printed source, Internet or any sources), this has properly acknowledged and referenced in accordance
with departmental requirements.
3-I have not used work previously produced by another student or any other person to hand in as my own.
4-I have not allowed, and will not allow, anyone to copy my work with the intention of passing it off as
his or her own work.
SIMILARITY INDEX (17%) ON DAY (15-12-2017 AT 05:52 PM)
SIGNATURE OF STUDENT: -----------------------------------------------------------------------------
SIGNATURE OF SUPERVISOR: ------------------------------------------------------------------------
SIGNATURE OF LIBRARIAN: --------------------------------------------------------------------------
vi
DEDICATION
Dedicated
To
MY LOVELY MOTHER,
Whose Prayers and Constant Encouragement Enabled Me to
Complete this Task of Learning
vii
LIST OF ABBREVIATIONS
8-oxodG 8-oxo- 7, 8 dihydro-2’-deoxyguanosine
8-oxoGuo 8-oxo- 7, 8 dihydroguanosine
AGE Advanced glycation end-products
ALT Alanine aminotransferase
AOPP Advanced Oxidative Protein Products
AST Aspartate aminotransferase
AUC Area Under Curve
BUN Blood urea nitrogen
CAT Catalase
CH2-THF 5, 10-Methlenetetrahydrofolate
CH3-THF 5-methltetrahydrofolate
CSβ Cystathionine beta
DIT Di-iodotyrosine
ECM Extracellular Membrane
ELISA Enzyme linked immune-sorbent assay
EGFR Endothelial growth factor receptor
ER Estrogen Receptor
FADPH Flavin adenine dinucleotide Phosphate
Glu Glutamate
Glu-Cys ligase Glutamate-Cysteine ligase
GNMT Glycine N-methyltransferase
GSH Glutathione
GSH Glutathione
GSH synthase Glutathione synthase
GSHPx Glutathione peroxidase
GSHr Glutathione reductase
viii
GSSH Glutathione disulphide
GST Glutamyl S-transferase
H2O2- Hydrogen peroxide free radical
I- Iodide ion
I2 Iodine molecule
IL Interleukin
LPO Lipid peroxidation
LPS Lipopolysaccharides
MATI/II Methionine adenosyltransferase
MDA Malondialdehyde
MMP Matrix metalloproteinases
MIT Mono-iodotyrosine
MPO Myeloperoxidases
MS Methionine synthase
MSR Methionine synthase reductase
MTHFR Methlene tetrahydrofolate reductase
NAC N-acetylcysteine
NFκB Necrosis Factor Kappa Beta
NLR NOD-like receptors
NLRB NOD-like receptors BIR domain
NLRC NOD-like receptors CARD domain
NO Nitric oxide
NOS Nitric oxide synthase
O2- Superoxide free radical
ONOO- Peroxynitrate
OSCC Oral Squamous Cell Carcinoma
PAF Prolactin activating factor
ix
PAMP Pathogen Associated Molecular Pattern
PB Phosphate Buffer
PCR Polymerase Chain Reaction
PIF Prolactin inhibitory factor
PLP Pyridoxal Phosphate
PUFA Polyunsaturated Fatty acids
r-Glu-Cys Gamma-Glutamate-Cysteine
RNS Reactive Nitrogen Species
ROC Receiver Operating Curve
ROS Reactive oxygen specie
RT3 Reverse tri-iodothyronine
SAH S- adenosylhomocysteine
SAHH S- adenosylhomocysteine hydrolase
SAM S-adenosyl methionine
SHMT Serine methylhydroxytransferase
SOD Superoxide dismutase
SOD Superoxide dismutase
T3 Tri-iodothyronine
T4 Tetra-iodothyronine
TAM Tumor Associated Macrophage
TBARS Thiobarbituric acid reactive substances
THF Tetrahydrofolate
TLR Toll-like receptor
TNF Tumor necrosis factor
TPP Total Plasma Peroxidases
TRH Thyrotropin releasing hormone
TSH Thyroid stimulating hormone
x
VIP Vasoactive inhibitory peptide
VitB12 Vitamin B12 (Cobalamine)
VitB6 Vitamin B6 (pyridoxine)
VitB9 Vitamin B9 (Folic acid)
xi
LIST OF SYMBOLS
SYMBOLS NAME
°C Degree centigrade
> Greater than
< Less than
rpm Rotation per minute
µl Micro liter
% Percentage
nm Nano meter
mg/dl Miligram per deciliter
mg/kg Miligram per kilogram
g/dl Gram per deci liter
IU/L International units per liter
xii
TABLE OF CONTENTS
"Bismillah al rahman al rahim"
i
SUPERVISORY COMMITTEE ii
EXAMINATION COMMITTEE iii
ACKNOWLEDGEMENT iv
DECLARATION OF ORIGANALITY v
DEDICATION vi
LIST OF ABBREVIATIONS vii
LIST OF SYMBOLS xi
TABLE OF CONTENTS xii
CHAPTERS DESCRIPTION PAGE #
CHAPTER ONE INTRODUCTION 1
CHAPTER TWO REVIEW OF LITERATURE 5
CHAPTER THREE MATERIALS AND METHODS 20
CHAPTER FOUR RESULTS 24
CHAPTER FIVE DISCUSSION 34
CHAPTER SIX SUMMARY 47
CHAPTER SEVEN CONCLUSION 51
CHAPTER EIGHT LITERATURE CITED 53
xiii
TABLE OF CONTENTS
S.# DESCRIPTION PAGE. #
1.0 INTRODUCTION 01
2.0 REVIEW OF LITERATURE 05
2.1 MATRIX METALLOPROTEINASES (MMPS)
IN OSCC
06
2.2 OXIDATIVE STRESS 11
2.3 NITRIC OXIDE 12
2.4 LIPID PEROXIDATION 13
2.5 CYTOKINES IN OSCC 13
2.6 ANTIOXIDANTS IN OSCC 16
2.6.1 ENZYMATIC ANTIOXIDANTS 18
2.6.2 NON-ENZYMATIC ANTIOXIDANTS 19
3.0 MATERIALS AND
METHODS
20
3.1 SOURCE OF DATA 21
3.2 INCLUSION CRITERIA 21
3.3 EXCLUSION CRITERIA 21
3.4 CHEMICALS 21
3.5 ESTIMATION OF CATALASE (CAT) 21
3.6 ESTIMATION OF THIOBARBITURIC ACID
REACTIVE SUBSTANCES (TBARS)
22
3.7 ESTIMATION OF SUPEROXIDE DISMUTASE
(SOD)
22
xiv
3.8 DETERMINATION OF AOPPs 22
3.9 AGEs PREPARATION AND DETERMINATION 22
3.10 ESTIMATION OF REDUCED GLUTATHIONE
(GSH)
22
3.11 ESTIMATION OF GLUTATHIONE
REDUCTASE (GR)
23
3.12 DETERMINATION OF GLUTATHIONE
PEROXIDASE (GPx)
23
3.13 DETERMINATION OF NITRIC OXIDE (NO) 23
3.14 ESTIMATION OF VITAMIN E 23
3.15 DETERMINATION OF VITAMIN-A 23
3.16 ESTIMATION OF MMP-2,9 and 11 ELISA 23
3.17 ESTIMATION OF IL-1α ELISA 23
3.18 ESTIMATION OF TNF-α ELISA 23
4.0 RESULTS 24
4.1 CIRCULATING STRESS BIOMARKERS
PROFILE OF ORAL CANCER PATIENTS VS
CONTROL
25
4.2 INFLAMMATORY BIOMARKERS PROFILE
OF ORAL CANCER PATIENTS Vs CONTROL
25
4.3 ANTIOXIDANT BIOMARKERS PROFILE OF
ORAL CANCER PATIENTS Vs CONTROL
26
5.0 DISCUSSION 35
6.0 SUMMARY 48
7.0 CONCLUSION 51
8.0 LITERATURE CITED 53
xv
LIST OF TABLES
S.# DESCRIPTION PAGE. #
TABLE-01: LEVEL OF DIFFERENT VARIABLES AND THEIR INTERPLAY IN
THE DEVELOPMENT OF OSCC
27
TABLE-02: PEARSON CORRELATION (TWO-TAILED) IN ORAL SQUAMOUS
CELL CARCINOMA (OSCC)
46
xvi
LIST OF FIGURES
S.# DESCRIPTION PAGE. #
FIGURE 0 1: EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL
IMPORTANCE AND THEIR INTERPLAY IN THE
DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA
(OSCC)
28
FIGURE 0 2: EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL
IMPORTANCE AND THEIR INTERPLAY IN THE
DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA
(OSCC)
29
FIGURE 0 3: EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL
IMPORTANCE AND THEIR INTERPLAY IN THE
DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA
(OSCC)
30
FIGURE 0 4: EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL
IMPORTANCE AND THEIR INTERPLAY IN THE
DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA
(OSCC)
31
FIGURE 0 5: EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL
IMPORTANCE AND THEIR INTERPLAY IN THE
DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA
(OSCC)
32
FIGURE 0 6: EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL
IMPORTANCE AND THEIR INTERPLAY IN THE
DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA
(OSCC)
33
FIGURE 0 7: PATHWAY INVOLVED IN PATHOGENESIS OF (OSCC) 45
CHAPTER ONE INTRODUCTION
SAIMA, 2017
1
INTRODUCTION
CHAPTER ONE INTRODUCTION
SAIMA, 2017
2
INTRODUCTION
The most frequently occurring mouth cancer, oral squamous cell carcinoma (OSCC),
largely affects the tongue and floor of the oral cavity. It is the development of painless
precancerous lesions appearing in either form of a lump, ulcer with raised fissures, erythroplakia,
leukoplakia or erythroleukoplakia followed by painful symptoms persisting for greater than two
weeks (Neville and Day, 2002). Furthermore, it is majorly asymptomatic which makes it hard to
be detected in initial stages and development of lymph node metastasis in the advanced stages
makes it more problematic hence contributing to worldwide elevated rates of mortality and
morbidity. Apart from this, a major setback is cancer relapse which has further emphasized the
urgency of better future treatment modalities (Jones et al., 1992; Brandwein-Gensler et al., 2005;
Kademani et al., 2005; Massano et al., 2006; Bell et al., 2007; Montoro et al., 2008 and
Rusthoven et al., 2010). OSCC, the sixth ranked cancer, has worldwide cases of about 4% where
95% of these are of OSCC alone. In addition, the incidence of oral cancer in Indian subcontinent
is escalating at an unprecedented rate where India has 45% and Pakistan has 10% cases of OSCC
(Williams 2000; Siddiqui et al., 2006; Baykara et al., 2013; Albano et al., 2013; Abbasi et al.,
2014 and Jafarian et al., 2015). From 2004 to 2009, over three million newly identified oral and
oropharyngeal neoplasm cases with over 7000 deaths were reported. It is alarming that out of one
million there is a 6.6% and 2.9% morbidity chance in men and women while a 2.9% and 1.4%
mortality risk in the same subjects respectively (Mehrotra and Yadav, 2006 and Sharma et al.,
2010). Since the last thirty years scientists have been unsuccessful to reduce the morbidity and
mortality rates associated with OSCC which is indeed shocking. Early diagnosis promises a
survival rate of 80-90% while a 15-50% rate if diagnosed at highly progressed stages (Scott et
al., 2006 and Markopoulos et al., 2010).
However, in recent years a burgeon of OSCC cases has been reported in individuals less
than 45 years specifically from 18 to 44 years (Warnakulasuriya 2009 and Patel et al., 2011). It
has been observed that younger people especially males are more prone to develop OSCC than
females due to excessive use of tobacco and tobacco associated products (Feller and Lemmer,
2012 and Krishna et al., 2013). A myriad of factors predispose the risk of OSCC including
family history, cannabis, excessive use of tobacco and tobacco products, regular alcohol intake,
narcotics and antioxidant deficient diet. Moreover Hepatitis C, Herpes virus, Candida albicans,
Human immunodeficiency virus, Human papilloma virus and Epstein Barr virus have also been
CHAPTER ONE INTRODUCTION
SAIMA, 2017
3
considered potential causative factors (Thavarajah et al., 2006; Garavello et al., 2008; Nagao and
Data, 2009; Shah and Gil, 2009; Petti 2009; Jalouli et al., 2010 and Nuovo 2011). In addition
inflammation, immune defects, potentially malignant disorders, defection in DNA repair
mechanisms, genetic polymorphism and mutation of certain genes (CYPIA1, GSTM1, CCND1,
ADH3, Cyclin D and N-acetyl transferase-2) also places a threat of oral cancer progression.
Although the prospective risk factors in different ethnic populations vary largely by far tobacco
and smokeless tobacco (betel quid, areca nut, gutka, maras powder) poses the greatest risk in
development of oral cancer. Tobacco smoking accounts for 75% of the reported cases, while
both smokers and alcoholics have a six fold risk of oral neoplasm than non-smokers and non-
alcoholics whereas those individuals practicing both habits have a fifteen fold risk of OSCC than
healthy individuals. By and large tobacco and alcohol in the West, gutka and betel quid in
Taiwanese, Maras powder in Turks, betel quid in Asians and in Indians areca nut, tobacco, and
betel quid along with alcohol consumption account for the onset of OSCC (Ogden 2005;
Subapriya et al., 2007; Su et al., 2007; Scully and Bagan, 2009; Attar et al., 2010de
FreitasCordeiro-silva et al., 2011; Marichalar-Mendia et al., 2011; Zygogianni et al., 2011;
Tanaka et al., 2011; Markopoulos 2012; Kurtul and Gokpinar, 2012).
Conventionally imaging techniques followed by blood, serum and biopsy samples are
used for OSCC detection but in the recent years the distinguished role of saliva as a diagnostic
tool has been widely accepted (Arellano-Garcia et al., 2008). Saliva without a doubt has an
advantage over serum in that it is easy to collect, noninvasive, safe, cost effective and in direct
contact with the cancerous site. It also provides an excellent source of genomic, proteomic and
oxidative stress biomarkers which are exploited for diagnostic, predictive and post therapy
monitoring purposes (Krishna Prasad et al., 2013; Cheng et al., 2014 and Bano et al., 2015).
Usually surgery followed by radiotherapy is the prime treatment in OSCC stages I and II
whereas for stage III and IV a combination of surgery, radiotherapy and chemotherapy is
utilized. Likewise immunotherapy, gene therapy, altered fractionated radiotherapy; cervical
lymph adenectomy, selective neck dissection, concomitant chemo-radiotherapy (CT-RT) and
targeted molecular therapy are also novel prospective treatments (Markopoulos, 2012). Recently
over-expressed matrix metalloproteinases (MMPs) have been found to be the culprits behind
various carcinomas including OSCC. The utilization of MMP-targeted synthetic drugs, Matrix
metalloproteinase inhibitors (MMPIs), specifically decreases the activity of various matrix
CHAPTER ONE INTRODUCTION
SAIMA, 2017
4
metalloproteases. On the basis of drug type MMP inhibitors are classified as peptidomimetic,
non-peptidomimetic, chemically modified tetracyclines, reform proenzyme structures, analogues
of inorganic pyrophosphates, bisbiguanide antiseptics, non-steroidal inhibitors of aromatose,
synthetic peptides based on PSP94, cyclophosphinamides, cyclophosphinamide based
hydroxamic acids, caffeoyl pyrrolidine derivatives, sulfonamide hydroxamates and
nonhydroxamates. Nanomedicine in combination with chemotherapeutics has no doubt also
shown promising results in terms of lesser side effects and tumour resistance. Recently
antioxidant therapy has gained popularity in treating OSCC (Rossi et al., 2010; Vilen et al.,
2013; Liboiron and Mayer, 2014; Oliviera et al., 2014).
Globally, a notable reason behind the drastic boom in OSSC cases is that the masses are
not fully cognizant of the hazardous effects of tobacco products and alcohol. In order to get rid of
this social taboo, a substantial number of awareness programs should be arranged to enlighten
the public about the debilitating effects of tobacco chewing, tobacco smoking, alcohol
consumption and excessive use of tobacco related products. The government can contribute by
taking strict steps on multiple levels to ban the sale and use of these noxious products. Likewise
emphasis on preventive measures such as opting for early screening, avoiding unnecessary
irradiation and consuming diet rich in iron and antioxidants can promise an oral cancer free life
(Kurtul and Gokpinar, 2012; Bansal et al., 2012 and Bhuvaneswari, 2014). Moreover the need
for effective MMP-2 and MMP-9 inhibitors is also in demand in order to stop OSCC in its track.
In addition by understanding the underlying disease mechanism, we can get a vantage point of
the potential predictive markers and novel treatment targets. Another aspect is to hinder
associated pathways leading to OSCC progression. Since the last decade, the search for novel
markers and effective treatments has spurred with the growing advancement in diagnostic tools.
In order to achieve improved outcomes and to minimize death rates, the need of the hour is to
detect oral neoplasms as earliest as possible and devise effective targeted treatments accordingly
(Bagan et al., 2010; Bello et al., 2010 and Prasad and McCullough, 2013). For this purpose, the
search for novel biomarkers is highly in demand and work on synthetic matrix metalloproteinase
inhibitors (MMPIs) has accelerated to a new level.
1.1 AIMS AND OBJECTIVES
The present study was to determine role of prognostic variables and their potential role in
the development of oral squamous cell carcinoma (OSCC).
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
5
REVIEW OF LITERATURE
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
6
2.0 REVIEW OF LITERATURE
To date, there are increasing number of appreciable data regarding promising, potential
salivary biomarkers at hand provided by (Khanna 2008, Markopoulos et al., 2010 and Tsuda and
Ohba, 2012; Krishna Prasad et al., 2013; Warnakulasuriya 2014; Bano et al., 2015). The current
research throws light on the combined role of MMPs specifically gelatinases, inflammatory and
oxidative stress markers involved in the pathogenesis of oral squamous cell carcinoma. Lastly,
the curative effect of antioxidants has also been conversed.
2.1 MATRIX METALLOPROTEINASES (MMPS) IN OSCC
These zinc dependent endopeptidases are produced according to the cell's need by wound
cells as well as inflammatory cells and are known to play essential roles in both normal and
diseased state. Under normal conditions, MMPs are secreted in very low amounts and they are
involved in tissue remodeling processes like ossification, placenta development, and embryonic
development and wound healing. Nevertheless in diseased states defected regulation leads to
their elevated level which contributes to rheumatoid arthritis, cardiovascular diseases, dermal
photoaging, autoimmune blistering disorders of skin, osteoarthritis, tumor invasion, metastasis
and periodontitis etc. As zymogens, these metalloendopeptidases either may be attached to
membranes or secreted in the extracellular matrix where proteolysis, other MMPs and serine
proteases activate them in order to act on different substrates ranging from matrix substrates to
bioactive entities. MMPs are strictly regulated by cytokines, stress and growth factors however
they can be rendered inactive through natural inhibitors including tissue inhibitors of
metalloproteinases (TIMPS) and α-2-macroglobulin or by synthetic matrix metalloproteinase
inhibitors (MMPIs). So far about 25 MMPs and four TIMPs (TIMP 1, TIMP 2, TIMP 3 and
TIMP 4) have been reported in vertebrates (Howard et al., 1991; O'Connell et al., 1994; Butler et
al., 1999 and Liu et al., 1997; Murray 2001; Sternlichit and Werb, 2001 and Hadler-Olsen et al.,
2011;).
On the basis of substrate specificity, sequence similarity and domain organization
metalloproteinases are categorized as: collagenases, gelatinases, stromelysins, matrilysins and
membrane type MMPs (MT-MMPs). Generally all MMPs consist of a signal peptide, a pro-
peptide having highly conserved Cysteine residues, a zinc containing catalytic domain and a
hemopexin like domain which is attached to the catalytic domain by a linker. But the striking
feature that separates gelatinases from other MMPs is the presence of a fibronectin type II like
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
7
domain (Egeblad and Werb, 2002; Nagase et al., 2006; Butler and Overall, 2009 and Klein and
Bischoff, 2011;).
One of the characteristic marks in cancer invasion is the deterioration of extracellular
matrix (ECM) which is efficiently done by matrix metalloproteinases (MMPs). Myriad MMPs
(MMP 1, 2, 3, 7, 9, 11, 13 etc.) take part in OSCC disease progression but the crucial role of
gelatinases has been widely established (Hong et al., 2000; Eglebad and Werb, 2002 and Lee et
al., 2008 and Vilen et al., 2013). Additionally studies show that sophisticated methods such as
Immunohistological analysis, In situ hybridization, PCR, ELISA, gelatin zymography, in situ
zymography, Confocal laser scanning microscopy, western blotting, northern blotting, southern
blotting, use of MMPIs or transfected cell lines and knockout animal models have been utilized
to estimate gelatinases successfully (Jin and Lloyd, 1997; Ikebe et al., 1999; Pirila et al., 2001;
Berg et al., 2002; Snoek-van Buerden and Von Den Hoff, 2005; Hotary et al., 2006; Patel et al.,
2007; Vilen et al., 2008; Suojanen et al., 2009; Liu et al., 2009; Singh et al., 2010).
MMP-2, a 72 kDa gelatinase, is physiologically found in both normal and neoplastic
endothelial cells, keratinocytes, fibroblasts and chondrocytes while gelatinase B, a 92 kDa
gelatinase, is normally expressed by macrophages, keratinocytes, monocytes and multiple
neoplastic cells. Both ECM destroyers occur in secreted forms where MMP-9 can be sojourned
by all four types of TIMPs (Westermarck and Kahari, 1999). Predominantly the secreted MMPs
have to be activated in order to perform their respective functions. The pro MMP 9 is naturally
activated extracellularly by unknown activators or by other MMPs which may be MMP 1, 2, 3,
7, 10, 13 and 26. Moreover cathepsin G, dentin matrix protein-1, TAT-2, plasmin, α-
chymotrypsin and trypsin also activate MMP-9 (Fridman et al., 1995; Knauper et al., 1997 and
Nakamura et al., 1998). MMP 3 cleaves pro MMP 9 at Glu59-Met60 as well as Arg106-Phe107
while MMP 26 cleaves at Ala93-Met94 (Ogata et al., 1992 and Zhao et al., 2003). Studies also
show that trypsin-2 activates the same zymogen at Arg87-Phe88 but in very small quantities
(Sorsa et al., 1997). Another activator is a serine protease in nature that has cleavage site at
Lys65-Ser66 (Vilen et al., 2008). Other proteolytic agents include chymotrypsin like domain and
plasmin (Mazzieri et al., 1997 and Han et al., 2002). Whereas gelatin bound and type IV
collagen bound MMP-9 zymogen is activated by allosteric activation, S-nitrosylation or ROS
mediated oxidation (Peppin and Weiss, 1986; Gu et al., 2002 and Bannikov et al., 2002).
Furthermore, in vitro studies indicate that all four types of TIMPs have active role in inhibiting
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
8
92 kDa gelatinase B (Howard et al., 1991; O'Connell et al., 1994; Liu et al., 1997 and Butler et
al., 1999). On the other hand, 72 kD gelatinase A (MMP-2) is activated by certain substances
hydrogen peroxide, MMP 1, 7, 13, 14, 16, 17, 24, 25 along with thrombin and bone sialoprotein.
MMP 2 further activates MMP-9 and -13. The gelatinase-A takes part in tumor invasion and
metastasis by activating other metalloproteinases to enhance its role in disease progression where
it is located in special cells called carcinoma associated fibroblasts (CAFs) in OSCC neoplasm.
Integrins, the adhesion molecule, has been reported to play a vital role in induction of OSCC and
elevates MMP-9 expression directly. Interestingly MMP-2 via the fibronectin-integrin pathway
(αVβ6 pathway) activates MMP-9 (Sutinen et al., 1998 and Impola et al., 2004).
Predominantly gelatinases have a wide range of substrates, the common ones in both
MMP-2 and -9 include collagens IV, V, VII, X, XIV (Welgus et al., 1990; Murphy et al., 1991
and Sires et al., 1995), fibronectin, gelatin, hyaluronidase-treated versican, galectin-3, MBP, a1-
AT, GST-TNF/TNF peptide, IL-1β, Aβ 1-40, aggrecan, elastin, proteoglycan link protein (Mast et
al., 1991; Desrochers et al., 1991; Senior et al., 1991; Fosang et al., 1993; Mitchell et al., 1993;
Nguyen et al., 1993; Gearing et al., 1994; Ochieng et al., 1994; Walsh et al., 1994; Sires et al.,
1994; Perides et al., 1995; Chandler et al., 1995; Fosang et al., 1996; Roher et al., 1994; Ito et
al., 1996; Backstrom et al., 1996). Apart from these laminin-1, osteonectin, laminin-5, APP695,
decorin, FGFR1, MMP-1, IGF-BP5, Ab 10-20, prolysyl oxidase fusion protein, IGF-BP3, MMP-
13, collagen I, collagen XI and MMP-9 are other substrates of neutrophil gelatinase (Miyazaki et
al., 1993; Fowlkes et al., 1994; Crabbe et al., 1994; Fridman et al., 1995; Aimes and Quigley,
1995; Le Page et al., 1995; Thrailkill et al., 1995; Levi et al., 1996; Panchenko et al., 1996;
Knauper et al., 1996; Giannelli et al., 1997; Imai et al., 1997 and Sasaki et al., 1997). On the
other hand, gelatinase B also acts on plasminogen, osteonectin and entactin (Sires et al., 1993;
Sasaki et al., 1993 and Patterson and Sang, 1997).
The normal cellular microenvironment when disturbed has been known to promote
various syndromes. In OSCC neoplasm tumor cells, stromal cells and ECM make up the tumor
microenvironment. Surprisingly, both tumor and stromal cells can largely amend each other’s
effects, facilitating cancer invasion and progression. Mainly tumor associated macrophage
(TAMs), endothelial cells (ECs) and carcinoma associated fibroblasts (CAFs) are pivotal players
in cancer progression (Li et al., 2014). In OSCC cancer cells, specialized carcinoma cells and
inflammatory cells are responsible for the release of MMP-9 and carcinoma associated
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
9
fibroblasts (CAFs) are in charge for the release of MMP-2 (Impola et al., 2004 and Fullar et al.,
2012). TAMs and CAFs cross talk with the cancer cells by autocrine and paracrine signaling and
therefore are of prime significance in OSCC. Usually in wound healing activated fibroblasts
form myofibroblasts, carry out their role, and are marked for death. Nonetheless when the
activated fibroblasts are not degraded, they result in carcinoma associated fibroblasts which
generate MMPs, cytokines and growth factors hence promoting neoplastic progression. Other
imperative stromal resident, macrophages, possess two phenotypes: the proinflammatory M1 and
the anti-inflammatory M2. Furthermore tumor associated macrophage (TAMs) have been said to
belong to the second phenotype. In addition growth factors and chemokines are behind the
accumulation of TAMs at the tumor site while TAMs are known to secrete growth factors,
chemokines and MMPs (Astekar et al., 2013).
The ECM disruptors, MMPs, are found largely throughout the different stages of
neoplasm but gelatinases play a crucial role in these processes (Zucker et al., 1993; Endo et al.,
1997; Torri et al., 1997; Vu et al., 1998; Hong et al., 2000; Lippman and Hong, 2001; Kawata et
al., 2002 and Zwetyenga et al., 2003). Multiple MMPs have been confirmed to play part in
tumor invasion most importantly MMP-1, 2, 7, 9, 13 and 14. The gelatinases are majorly
involved in the onset of OSCC where gelatinase B (MMP 9) is an aggressive multifaceted
endopeptidase which provides its role in tumor invasion, metastasis, inflammation and
angiogenesis by making ECM degradation possible. Apart from this, these endopeptidases make
distinct interactions with cell too. It has been observed that MMP 2 interacts via cellular receptor
integrin αVβ6 while MMP 9 interacts through CD44, integrin pathway or α2 collagen chain. The
activated MMP-9 effectively degrades ECM components giving way to tumor invasion.
Consequently, a great amount of released cytokines and chemokines provides feasible
environment for inflammation. Throughout inflammation stage, oxidative stress makes matters
worse by enhancing inflammation. A great bunch of emanated inflammatory cytokines,
chemokines, matrix proteinases and free radicals expedite angiogenesis. The hypoxic condition
provides increased expression of VEGF, an angiogenic cytokine, along with its receptor in
specific cancer cells, endothelial cells, tumor associated cells.
It has been observed that in OSCC the HIF-1α is upregulated which is the reason behind
elevated levels of gelatinases and hence decreased prognosis (Bergers et al., 2000; Deryugina
and Quigley, 2006 and Chaudhary et al., 2015). MMP-9 has a dual role in angiogenesis where it
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
10
may act as angiogenic or anti-angiogenic depending on the situation (Rundhaug 2003; Liu et al.,
2009 and Reuter et al., 2010). Various growth factors play essential roles in the first step of
tumorigenesis. For instance overexpression of TGF-β1 is responsible for spiked expression of
MMP-9 in OSCC studies. It has been discovered that Snail, the transcription factor, aids in
elevating MMP-9 expressions (Shi and Massague, 2003; Bjorklund and Koivunen, 2005 and Sun
et al., 2008).
Sufficient data supports the versatile role of gelatinases in oral squamous cell carcinoma.
Gelatinase B (MMP-9) has a significant role in OSCC progression and its expression along with
activity has been thoroughly weighed (Jafarian et al., 2015; Jordan et al., 2004 and Van den
Steen et al., 2002). While Guttman et al. stated that no correlation could be established between
primary tumor size and MMP-9 levels in tongue squamous cell carcinoma patients. On the
contrary, 92 kD gelatinase B is reported to be enhanced in oral cancer (Roukolainen et al., 2005).
A study by Katayama et al. showed that elevated MMP 9 expression was in correlation with poor
prognosis and lymph node metastasis. Whereas De Vicente et al. reported that clinical variables
are not associated with enhanced MMP 9 levels; moreover their study also shows that gelatinases
are involved in tumor invasion and their higher expression is seen with lymph node involvement
whereas MMP-9 has vital role in metastasis. In addition, ethanol has been found to positively
affect expression of gelatinases. Further Hong et al. found that increased expression of MMP-9 is
majorly associated with metastasis. Yet Ikebe et al. showed that increased expression of both
gelatinase A and B in OSCC was in correlation with only tumor invasiveness. Likewise Kato et
al. investigated the association of gelatinases with different tumor stages and concluded that
MMP 9 levels were elevated in OSCC but the active form of MMP 9 was less in quantity as
compared to the levels of activated MMP 2, hence MMP 2 has correlation with advanced stages.
Mukherjee et al. showed that gelatinases are highly involved in cancer and pre-cancer states.
Apart from this, Kato et al. found that gelatinolytic activity in OSCC is due to activated 72 kD
gelatinase A. In a different study moderate expression of MMP-2 was seen while MMP-9 levels
were the highest (Mishev et al., 2014). Another investigative study discovered that it is the
increased gelatinases in OSCC patients that leads to their low survival rates (Yorioka et al.,
2002). Although studies show that gelatinases are expressed in OSCC and the role of gelatinase
in tumor invasion has been established but there is still a contradiction whether MMP-2 plays a
role in metastasis or not. As the part played by gelatinases in OSCC development has not been
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
11
completely understood and elucidated, therefore the role of MMP-2 and MMP-9 is of intense
research now a days.
2.2 OXIDATIVE STRESS
Reactive oxygen and nitrogen species are essentially synthesized in the body to accomplish
certain advantageous tasks but if their levels are increased incredibly would be harmful for the
body. The vulnerable biomolecules carbohydrates, lipids, proteins and nucleotides come under
the devastating attack of these unstable species resulting in DNA damage, genetic mutations and
chemical modifications eventually leading to multifarious diseases (Kang 2002; Van Wijk et al.,
2008; Yokoe et al., 2009; Yadav and Ramana, 2013; Ohnishi et al., 2013). The notorious
oxidative stress is a result of exogenous and endogenous factors. Arguably, certain organelles
peroxisomes, mitochondria and enzymes xanthine oxidase, P450 complex and NADPH oxidase
(NOX) family endogenously produce reactive species whereas noxious chemicals, ultraviolet
radiation, smoking, exercise and environmental pollutants are exogenous sources. It is affirmed
that reactive oxygen species (ROS) have implications in initiation, promotion and progression of
cancer including OSCC (Patel et al., 2009 and Zunli et al., 2015).
Mitochondria are the foremost organelle producing reactive oxygen intermediates and
reactive nitrogen species. Initially superoxide (O2·-) is formed which further forms hydroxyl
radical (OH-) and hydrogen peroxide (H2O2) under aerobic and hypoxic conditions. In addition
superoxide reacts with nitric oxide to form peroxynitrite (Jomova et al., 2010). Moreover, the
endoplasmic reticulum (ER), ubiquitous enzymatic NOX family, cytochrome P450, uncoupled
NO synthase, xanthine dehydrogenase (XDH), cyclooxygenase (COX) and xanthine oxidase
(XO) also contributes in ROS production (Pritsos 2000; Nishino et al., 2008; Popov 2012 and
Segal et al., 2012). Tobacco, smokeless tobacco and alcohol are well-known carcinogens capable
of producing highly reactive free radicals and reactive oxygen species (ROS) in biological
systems namely superoxide anion, hydrogen peroxide, organic peroxides, hypochlorous acid and
hydroxyl radicals which in the long run causes oxidative stress (Yu, 1994 and Bagul et al.,
2013). Apart from other organelles, the main source of oxidative stress is mitochondria which
actively generate ROS, reactive nitrogen species (RNS) and lipid peroxidation by products.
Interestingly free radicals can trigger inflammation while chronic inflammation can set off
oxidative stress, hence providing evidence that both inflammation and oxidative stress are
intertwined (Bektas-Kayhan, 2012 and Lugrin et al., 2014). Further, hypoxia mediated
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
12
production of mitochondrial reactive nitrogen species (RNS) produces lipid peroxidation
byproducts 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA). The reactive species
release inflammatory cytokines and chemokines which activate inflammatory cells hence
proceeding to chronic inflammation.
Inflammatory cells in turn recruit inflammatory cytokines, chemokines and processed
proteins to activate a wide range of transcription factors, hence indirectly initiating oxidative
stress (Hussain et al., 2003 and Poyton et al., 2009). In addition, pro-inflammatory cytokines
(CXCL -1, -4, -8, -9, -11, and 14), proforms of cytokines (pro TNF-α, proIL-1β) and certain cell
adhesion proteins undergo processing and at last contribute to inflammation. All these routes
eventually contribute in the tumor growth, inflammation and angiogenesis. Additionally 8-
hydroxy-2’-deguanosine (8-OHdG), the genetic biomarker pointing towards DNA damage, is an
important signature molecule for predicting neoplasia and oxidative stress (Valavanidis et al.,
2009). Its elevated levels have been reported in OSCC patients (Agha-Hosseini et al., 2012).
Likewise advanced oxidative protein products (AOPPs), a novel biomarker depicting oxidative
stress (OS), was stated to be drastically increased in oral cancer patients (Barut et al., 2012).
2.3 NITRIC OXIDE
Nitric oxide (NO), an endogenous gas with a short lifespan, has crucial role in redox
biology including respiration, vasodilation, immune response, cell migration and apoptosis.
Exceeded and unchecked levels of NO serve as "messenger of death”, hence triggering certain
illnesses. Studies have confirmed remarkably enhanced levels of nitric oxide (Choudhari et al.,
2012). NO, NO2, NO3 are taken as nitrosative stress markers and they were conversed to be
enhanced in the saliva of OSCC patients (Bahar et al., 2007; Rasheed et al., 2007 and Gokul et
al., 2010). While Gokul et al. reported increased nitric oxide levels in saliva, tissue and blood
samples of individuals suffering from OSCC. Korde et al. reported exceeding levels of total
nitric oxide (NO) and malondialdehyde (MDA) which gave evidence of the active role of ROS
and RNS in oral carcinogenesis. Hence prolonged exposure to ROS has not only destructive
effects on cellular structure and function but also instigates somatic mutations thus leading to
cancer (Fang et al., 2009 and Khandrika et al., 2009).
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
13
2.4 LIPID PEROXIDATION
Lipids undergo peroxidation during stress, causing their destruction. The highly unstable
entities, ROS, attack the polyunsaturated fatty acids (PUFA) in lipid bilayer membranes resulting
in the disruption of biomembranes and deposition of lipid peroxides namely lipid hydroperoxides
(LHP) and malondialdehyde (MDA). In mammals, MDA forms DNA adducts hence contributing
to DNA insults. In addition, this reactive aldehyde can possibly cause genotoxicity, cancer and
mutations. In addition association between cancer and lipid peroxidation has been conveyed too
(Baskaran et al., 1999 and Ray and Hussein, 2002). These end products serve as established
indicators of lipid peroxidation; hence they can be utilized as sophisticated biomarkers of cellular
damage. On the contrary, malondialdehyde (MDA) is widely taken as the indicator of lipid
peroxidation (Jacob and Burri, 1996; Beevi et al., 2004 and Ayala et al., 2014).
It is thought that the raised circulating lipid peroxides may attribute to cancer (Gokul et
al., 2010), and sufficient data provides evidence that elevated levels of MDA were found in
OSCC subjects (Manoharan et al., 2005; Patel et al., 2007; Rasheed et al., 2007; Salzman et al.,
2009; Korde et al., 2011; Agha-Hosseini et al., 2012; Barut et al., 2012; Shilpasree et al., 2013
and Ganesan and Kumar, 2014). In addition increased MDA levels in blood and tissue samples
were reported by Gokul et al. while elevated salivary MDA was reported by Rasool et al.,
Metgud and Bajaj; Gupta et al. and Shetty et al. The study by Rasool et al. as well as Ganesan
and Kumar showed that saliva is a better option than blood in terms of evaluating
malondialdehyde. Other studies, reported that MDA levels in OSCC subjects prior to
radiotheraphy were low but greatly enhanced after radiotherapy (Patait et al., 2011). Similarly
levels of thiobarbituric acid reactive substances (TBARS) were also reported to be raised in
individuals suffering from oral cancer (Manoharan et al., 2005; Srivastava et al., 2012 and
Thomas and Sethupathy, 2015). In contrast, the individuals with reduced levels of lipid
peroxidation and TBARS are said to be less liable to oxidative insults owing to their excellent
antioxidant system (Subapriya et al., 2002 and Kolanjiappan et al., 2003).
2.5 CYTOKINES IN OSCC
The immune system protects the body against harm at all cost yet persistent deviation in
homeostasis leads to chronic inflammation. A number of external and internal factors may
prompt inflammation including viruses, allergens, microbes, tobacco, alcohol, autoimmune
disorders, high calorie diet, malicious chemicals, obesity, radiation and chronic maladies
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
14
(Aggarwal et al., 2009 and Schetler et al., 2010). Importantly, inflammation has been known to
give rise to neoplasia, neurodegenerative diseases, bone disorders, heart disease, dental ailments
and chronic pain (Seaman 2006 and Seaman 2007).
OSCC has a close link with immune system and with the advancement in its severity, a
rapid decline in immune function has been known. In addition, chronic inflammation has
potential of causing oxidative stress and excessive exposure to oxidative stress in turn gives rise
to chronic inflammation which ultimately leads to onset of oral squamous cell carcinoma (Osaka
et al., 2000; Bartsch and Nair, 2006 and Nathan and Cunningham-Bussel, 2013). Moreover
increased bacterial exposure sets off inflammation leading to oxidative stress, reduction of
antioxidants and eventually elevated risk of serious infections and dental diseases (Nishida et al.,
2000 and D’Aiuto et al., 2010).
The oral epithelium, naturally, protects itself from external and internal damaging agents.
On the contrary, the copious use of tobacco products not only harms the oral mucosal epithelium
but also poses a great possibility for certain oral infections (Lee et al., 2012 and Feldman and
Anderson, 2013). The exogenous and endogenous molecular patterns (PAMPs and DAMPs) are
recognized by special pattern recognition receptors (PRRs) which comprise of Toll-like receptors
(TLRs) and NOD-like receptors (NLRs). TLRs and NLRs are crucial receptors for the innate
defense mechanisms yet unchecked TLR activation is associated with multifarious ailments
(Reuven et al., 2014). NLRs reside in the cytosol, sense multitude danger signals, have various
subfamilies and are activated by TLRs. The NLRB (NOD-like receptors BIR domain) and NLRC
(NOD-like receptors CARD domain) subfamily forms inflammosomes, later directing activation
of pivotal inflammatory cytokines IL-1α and IL-1β (Martinon et al., 2009 and Kersse et al.,
2011). The nucleotide binding oligomerization domain (NOD)-like receptors consist of NOD1
and NOD2, both of which have been found to be expressed in mouth cavity provided that NOD1
is more prevalent in oral epithelium (Sugawara et al., 2006; Uehara et al., 2007 and Uehara and
Takada, 2008).
To date, 12 TLRs are known in mammals and all TLRs have the capability to recognize
DAMPs and PAMPs. TLRs are only observable in oral cancer as the normal epithelium lacks
them. Toll-like receptors find their wide use in immunity, promoting cancer progression and
secreting cytokines. The TLR-activated neoplastic cells release inflammatory cytokines and
chemokines resulting in activating immune cells in the vicinity, which in turn secrete cytokines
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
15
and chemokines (Heo et al., 1989 and Wang et al., 2006). A recent study has shown that TLR9 is
greatly expressed in OSCC and its role in tumor growth is by means of elevated cyclin-D1,
which has been known to activate TLR9. Also these receptors have role in increasing expression
of gelatinases. Whereas the transcription factors AP-1 and NF-kB are activated by TLRs and
have been identified as the regulator of MMP-2. In addition, the activated Fos and Jun-D genes
lead to elevated AP-1 activity. Interestingly, TLR9 was not found to influence NF-kB (Ruan et
al., 2014). Literature highlights that TLRs varied in diverse OSCC stages. TLR4 was found to be
linked with lymph node metastasis whereas TLR2 expression was linked with both invasion and
lymph node metastasis. Apart from this, TLR7 levels were stated to be tumor grade dependent
while TLR8 levels surged with the exacerbation in tumor grade (Esmaeeli et al., 2015).
It has been reported that those patients had better disease outcomes that had greater
immune cells in the vicinity of tumor (Scully and Bagan, 2007). In addition inflammatory cells
especially tumor-associated macrophages (TAMs) are actively involved in raising reactive
oxygen species (ROS) levels by recruiting certain cytokines (IL-6, IL-1β, TNF-α), chemokine
(NFκB, iNOS, COX-2, HIF, STAT3, Nrf2, NFAT) and metabolites of arachidonic acid. For
instance arachidonic acid derivatives (AADs) are pro inflammatory in nature and they contribute
in ROS-induced inflammation by activating neutrophils. Similarly other pro-inflammatory
substances nitric oxide (NO), tumor necrosis factor (TNF-α), Interleukin-6 (IL-6) and IL-1β are
generated by Lipopolysaccharide (LPS) (Dana et al., 1994; Zallen et al., 1998; Lee et al., 2004;
Lu et al., 2006; Naik and Dixit, 2011 and Ho and Kuo, 2014). Additionally, free radicals are also
known to raise the levels of inflammatory cytokines including tumor necrosis factor alpha (TNF-
α) and tumor growth factor beta (TGF-β) which facilitates chronic inflammation (Goossens et
al., 1995). Similarly tumor necrosis factor (TNF-α) is also a potential predictive inflammatory
biomarker for oral neoplasms and is known to trigger the NFκβ pathway therefore facilitating
tumor progression. Furthermore the role of ROS-induced interleukin 6 (IL-6) and chemokine IL-
8 in the onset of cancer has also been reported (Reuter et al., 2010).
IL-8, a post-inflammatory cytokine, is a useful biomarker for early detection of oral
cancer disorders and OSCC. Brinkmann et al. utilized PCR and ELISA techniques in order to
observe the trends of salivary proteomic markers in Serbian population and their findings
showed raised IL-8. Furthermore ROS and macrophages has also been found to up regulate an
angiogenic cytokine vascular endothelial growth factor (VEGF), TNF-α, IL-6, IL-1 and GM-
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
16
CSF hence accelerating angiogenesis. Likewise macrophages secrete COX-2, MMP-2, MMP-9,
MMP-7, MMP-12 and thymidine phosphorylase hence facilitating migration of endothelial cells.
The role of VEGF in carcinogenesis has been confirmed by the studies (Pandya et al., 2006).
Also, it is found that angiogenic cytokine VEGF is elevated in OSCC (Mukherjee et al., 2010).
Interestingly, MMPs and cytokines have entwined connections where MMP activation and
expression can be controlled by inflammatory cytokines. A study reports that disruption of a
matrix protein, decorin, releases anchored TGF-β from the matrix. Moreover, sheddases and
convertases have also been reported to free receptors, adhesion molecules and cytokines from the
membranes (Arribas et al., 1996; Imai et al., 1997 and Hooper et al., 1997). Nevertheless early
diagnosis of inflammatory growth factors, adhesion molecules and cytokines may provide us a
better outlook of OSCC progression.
2.6 ANTIOXIDANTS IN OSCC
In order to cope with oxidative stress, the body has its own specialized mechanism to
neutralize the adverse effects of ROS and RNS via antioxidants. These scavengers are classified
as enzymatic and non-enzymatic and may be exogenous, endogenous, naturally produced or
taken as supplements. Largely, antioxidants work by preventing and repairing the already caused
damage therefore enhancing immunity and minimizing disease risks. Furthermore the
disturbance in the native production of pro-oxidants and antioxidants provides feasible
environment for the onset of multiple diseases including OSCC (Gonzales et al., 1984 and Pham-
Huy et al., 2008). In oral cancer (OC), the oral epithelial layer is greatly affected by tobacco and
is prone to damage by ROS and RNS. Tobacco users have an escalated level of reactive species
which potentially reduce antioxidants from the system. Likewise increments of ROS and RNS
have been observed in oral pre-cancer as well as cancer. In the course of carcinogenesis, scanty
or dwindling enzymatic and non-enzymatic antioxidants set off oxidative stress hence formation
of intermediates of reactive nitrogen (RNI) and oxygen (ROI). Later, an elevation in oxidative
stress increases the need for essential antioxidant nutrients in the body as in the case of tobacco
abusers. The inhibitory, preventive and reversal characteristics of antioxidants are well
established in multitude diseases, therefore they have a protective effect against oral cancer.
Moreover antioxidant therapy has gained wide speculation in the recent past few years
(Choudhari et al., 2014).
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
17
Oxidative stress may also be triggered by deficiency or inhibition of antioxidant enzymes.
Antioxidants have been found to reverse the harmful effects of nicotine (Figuero et al., 2006).
Surprisingly, topical antioxidants have excellent results on oral, periodontal, skin and gingival
cells (San Miguel et al., 2010). The protective effects of Lactoferin, black raspberries and black
tea polyphenols in dental disorders have been well established. Animal models and human
studies have shown that freeze dried black raspberries caused an appreciable decline in dysplasia
(Stoner et al., 2007 and Letchoumy et al., 2008). The effective roles of flavonoids have been
found to minimize the expression of inflammatory substances in macrophages and monocytes
residing in the gingival connective tissue. Moreover flavonoids such as luteolin, quercitin and
genistein have been reported to regulate NO formation of LPS-stimulated human gingival
fibroblasts. Luteolin, specifically is involved in down regulating MAP kinases hence hindering
inflammation (Gutierrez Venegas et al., 2006). Ferrulic acid, a vital component of raspberries,
has been reported to scavenge free radicals. The anticancer properties of ferrulic acid have been
known (Lesca 1983; Mori et al., 1999; Kampa et al., 2004 and Lee 2005;). Vitamin E, Ferrulic
acid and Vitamin C in combination decreased OS and prevented formation of thymidine dimers
in skin (Srinivasan et al., 2007). The therapeutic role of alpha tocopherol in treating and
preventing periodontal pathology, reducing wound healing time and oxidative stress has been
known (Chapple and Matthews, 2000 and Barbosa et al., 2009). It is suggested that the lipid
soluble vitamin E may diminish hydroxyl radicals (Royack et al., 2000). Studies also show that
reduced levels of serum folate have been linked to periodontal illnesses (Yu et al., 2007).
Antioxidants are potential predictive biomarkers in multiple diseases and they have been
found to be progressively decreased in OSCC (Rasool et al., 2014 and Thomas and Sethupathy,
2015). Rasheed et al. reported depleted antioxidants in head and neck squamous cell carcinoma
(HNSCC) whereas Bahar et al. found diminished antioxidants in oral cancer subjects. Total
antioxidant capacity (TAC), a prognosticator of antioxidant status, has been found to
progressively reduce in numerous malignancies including oral cancer patients (Hedge et al.,
2013). Apart from this, the reduced levels of total antioxidant capacity (TAC) in OSCC patients
were said to be owing to both oxidative and nitrative stress (Korde et al., 2011 and Agha-
Hosseini et al., 2012). Salivary antioxidants albumin, glutathione, vitamin C, uric acid and
antioxidant enzymes have been seen to be diminished in oral illnesses (Bhuvaneswari 2014).
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
18
2.6.1 ENZYMATIC ANTIOXIDANTS
The enzymatic scavengers superoxide dismutase (SOD), catalase (CAT), glutathione
peroxidase (GPx) and glutathione reductase (GRx) are actively involved in eliminating reactive
species where SOD, CAT and GPx are considered the "backbone of antioxidant defense
mechanism" (Manoharan et al., 2005 and Fiaschi et al., 2005). Superoxide dismutase (SOD), a
ubiquitous antioxidant, degrades the unstable superoxide anion into less reactive molecular
oxygen and another ROS, hydrogen peroxide (Pham-Huy et al., 2008). Likewise catalase (CAT)
further neutralizes the hydrogen peroxide forming water. Other scavengers belong to the famous
glutathione system that efficiently removes oxidants from the biological system. The four
selenium containing most abundant antioxidant, Glutathione peroxidase (GPx), acts on organic
hydroperoxides and hydrogen peroxide while glutathione pro-oxidase scavenges on lipid
hydroperoxides (Khanna and Karjodkar, 2006 and Bathi et al., 2009). In addition the salivary
enzyme glutathione-S-transferase (GST) possesses anti-neoplastic properties and prevents DNA
damage (Shiboski et al., 2005).
Literature demonstrated that elevated levels of antioxidants during diseased states are due to
the burden on defense system to remove oxidants from the body, yet decreased levels were
linked to the extent of disease progression (Rehman, 2007). Bagul et al. found elevated levels of
SOD and GPx in OSCC whereas in other studies, SOD, CAT and GPx were reported to be
diminished in the same subjects (Manoharan et al., 2005; Gupta et al., 2009; Srivastava et al.,
2012 and Shilpasree et al., 2013). Other studies, indicated that tumor samples showed minimum
levels of SOD and CAT while GPx, glutathione reductase (GR) and glutathione-S-transferase
(GST) were enhanced in blood samples from the same subjects (Subapriya et al., 2002 and
Fiaschi et al., 2005), this conflicts with the study by Gokul et al. which showed decreased SOD
and CAT in both type of samples. A speculating study concluded that SOD levels fluctuate in
different malignant conditions where oral cancer has the most minimum levels (Gurudath et al.,
2012; Shetty et al., 2013 and Hegde et al., 2013). While enhanced levels of metastatic marker
SOD2 was reported to be linked with lymph node metastasis in OSCC (Ye et al., 2008). In
addition, contrasting results were reported in OSCC patients and individuals undergoing
radiation treatment (Sabitha and Shayamaladevi, 1999; Yang et al., 2002; Suprapaneni and
Raman, 2006; Bogdanovic et al., 2008 and Pejic et al., 2009;). Vurumadla et al. observed that
although both chemotherapy and radiotherapy were responsible for the elevation in oxidative
CHAPTER TWO REVIEW OF LITERATURE
SAIMA, 2017
19
stress in OSCC, the latter was found to be more responsible in raising oxidative stress. Moreover
the antioxidant enzymes SOD, GPx and CAT were found to be reduced after radiotherapy.
2.6.2 NON-ENZYMATIC ANTIOXIDANTS
Reduced glutathione (GSH), vitamin A, Vitamin C and Vitamin E are known to play
protective roles in multitude diseases. The low molecular weight, intracellular glutathione is the
most abundant non-protein thiol in the body. It performs multiple functions including regulation,
metabolism and defense against scavengers. It is observed that minimized and depressed levels
of GSH have been attributed to setting off a myriad number of diseases and inflammation
(Anderson, 1998 and Wu et al., 2004). Study by Subapriya et al. and Fiaschi et al. reported
raised GSH levels whereas Srivastava et al. found reduced levels of GSH in blood of OSCC
patients. In addition, glutathione levels were reported to be greatly reduced in different stages of
carcinoma (Hegde et al., 2013). Likewise another study showed that oral cancer greatly
minimized the available glutathione in contrast to potential malignant disorders (Shetty et al.,
2013). In addition, Vitamin E, the strong free radical scavenger, was found to be dangerously
reduced in oral cancer (OC) patients (Raghuwanshi et al., 2012). Additionally Vitamin E and
GSH were reported to be diminished in plasma and red blood cells (Manoharan et al., 2005 and
Metgud and Bajaj, 2014). On the other hand, Vitamin C levels were reported to be increased in
OSCC tumor samples but ascorbic acid and iron levels were found to be decreased in oral
submucous fibrosis (Fiaschi et al., 2005 and Guruprasad et al., 2014).
CHAPTER THREE MATERIALS AND METHODS
SAIMA, 2017
20
MATERIALS AND METHODS
CHAPTER THREE MATERIALS AND METHODS
SAIMA, 2017
21
3.0 MATERIALS AND METHODS
3.1 SOURCE OF DATA
This study was performed to evaluate the role of inflammatory and biochemical stress
markers in pathogenesis of oral cancer. All the patients were selected and screened at Shoukat
Khanum Hospital, Lahore. Fifity patients with diagnosed oral squamous were included in the
study. Informed consent was taken from them before starting this research. Whereas twenty
healthy patients that neven use tobacoo were taken as controls. The protocols that were used to
perform this research were approved by the Research Ethical Committee of The Institute of
molecular biology and biotechnology, The University of Lahore. Five ml of blood sample was
withdrawen from each participant from their cubital vein that was centrifuged within an hour and
stored at -70˚C under specific wiles.
3.2 INCLUSION CRITERIA
Subjects having history of any tobacco use and were diagnosed oral cancer through
biopsy and pathological experiments were included in this study.
3.3 EXCLUSION CRITERIA
Subjects that were on medication, using alcohol or diagnosed with any significant
systemic disease were excluded from the study.
3.4 CHEMICALS
Chemicals that were used for this study to perform experiment were taken from
sigma/Invitrogen Chemical Co. (St. Louis, Mo, USA).
3.5 ESTIMATION OF CATALASE (CAT)
Method of Aebi (1974) was used to measure the levels of Catalase (CAT) from serum.
Protocol was performed using the spectrophotometer. CAT was measured by taking the
absorbance at 230nm. Reaction was started in the cuvette by adding serum sample 0.01PB and
2mM hydrogen peroxide (H2O2). U/g is the unit used to represent the specific activity of
catalase. The absorbance value was then compared with the known value of catalase by making a
standard curve.
CHAPTER THREE MATERIALS AND METHODS
SAIMA, 2017
22
3.6 ESTIMATION OF MELONDIALDEHYDE (MDA)
Levels of MDA were measured in serum sample through calorimeter by using the method
of Ohkawa et al, (1979). In this protocol following chemicals were added in the test tube
containing 200μl sample
200μl of 8.1% SDS, 1.5 ml of acetic acid (CH3COOH) (20%) and 1.5 ml of TBA (0.8%)
then test tube was kept on heapting for 60 min. then test tube was cooled down and 4 ml of n-
butanol was added and was centrifuged for 10 min at 3000 rpm. After centrifugation upper layer
of was separated with pipette and the absorbance was taken at 532nm on spectrophotometer.
3.7 ESTIMATION OF SUPEROXIDE DISMUTASE (SOD)
Kakkar, (1984) method was used to estimate the level of Superoxide dismutase (SOD) in
serum. This protocol was performed in falcon tube, 100μl of serum sample was added along with
sodium phosphate buffer having pH 8.3, , Nitro blue tetrazolium (0.3ml; 300μM),
phenazinemethosulphate (0.1ml; 186μM) and NADH (0.2ml; 750μM). Then falcon tube was
incubated on 30°C for one and a half minute (90 sec) after incubation glacial acetic acid (0.1ml)
was added then 4.0ml of n-butanol was added and centrifuged at 4000rpm for 10 minutes.
Absorbance was taken of upper layer of butanol at 560 nm.
3.8 DETERMINATION OF AOPPs
Method of Witko-Sarsatet al,(1996) was used to perform the protocol of estimation of
Advanced oxidation of protein products (AOPPPs). Levels of AOPPs were estimated using size
exclusion chromatography.
3.9 AGEs PREPARATION AND DETERMINATION
AGEs that are significant markers of inflammation were determined by the method of
Goldin et al., (2006).
3.10 ESTIMATION OF REDUCED GLUTATHIONE (GSH)
Method of Moron et al, (1979) was used to measure the levels of GSH in serum. This
method is used to estimate both oxidized and reduced form of GSH. The absorbance values were
then compared with known value of GSH by making a standard curve (Tietze, 1969).
CHAPTER THREE MATERIALS AND METHODS
SAIMA, 2017
23
3.11 ESTIMATION OF GLUTATHIONE REDUCTASE (GR)
Glutathione reductase was evaluated by using method of David and Richard (1983).
3.12 DETERMINATION OF GLUTATHIONE PEROXIDASE (GPx)
Aebi and Bergmeyer, (1983) method was used to measures the level of glutathione
peroxidase (GPx) through spectrophotometer by using buffer/enzyme reagent.
3.13 DETERMINATION OF NITRIC OXIDE (NO)
Levels of NO were measured using Griess reagent by following the protocol of Bredt and
Snyder, (1994).
3.14 ESTIMATION OF VITAMIN E
Vitamin E was evaluated in samples by the Emmerie-Engel reaction as reported by
Rosenberg (1992).
3.15 DETERMINATION OF VITAMIN-A
Vitamin-A was determined by the method of spectrophotometer as an ingredient of
pharmacopeial preparation as adopted in 1956 IUPAC USPharmacopeial Forum (Lawrence-
Evans, 2015).
3.16 ESTIMATION OF MMP-2, 9 and 11
Levels of MMPs 2, 9 and 11 were measure through commercially available ELISA kit
(BioVendor).
3.17 ESTIMATION OF IL-1α ELISA
IL-1α levels were determined by using human ELISA kit (BioVendor)
3.18 ESTIMATION OF TNF-α ELISA
ELISA Kit ( Enzo Pharma) was used to measures the levels of Tumor Necrosis Factor-
alpha(TNF-α).
CHAPTER FOUR RESULTS
SAIMA, 2017
24
RESULTS
CHAPTER FOUR RESULTS
SAIMA, 2017
25
4.0 RESULTS
Fifty diagnosed oral cancer patients and twenty healthy subjects were included in the
study. Significant biochemical markers, inflammatory, stress markers and antioxidants were
measured to determine the effect of these markers in oral cancer proliferation.
4.1 CIRCULATING STRESS BIOMARKERS PROFILE OF ORAL CANCER
PATIENTS VS CONTROL
The results regarding stress biomarkers MDA, isoprostanes 8-OGdG, NO, AGES and
AOPPs are shown in table 1. According to table 1 levels of MDA were increased (1.36±0.38
nmol/ml) significantly in patients suffered from OSCC as compared to healthy controls
(3.87±1.10 nmol/ml). Where as the levels of 8OHdG and Isoprostanes those were the byproducts
of lipid peroxidation were increased significantly (P=0.012 and P=0.014) in subjects (68.99±5.29
and 0.95±0.005 pg/ml) in comparison to controls (0.88±0.001 and 0.04±0.003pg/ml
respectively). Levels of NO were measured to evaluate the levels of Reactive Nitrogen species
(RNS) in the body that induce oxidative stress. Table 1 depicts that levels of NO were increased
(55.66±9.15 Um/L) significantly as compared to healthy controls (19.19±1.31 Um/L). AGEs and
AOPPs were measured to evaluate the degenerative diseases and oxidative stress in the body.
Advanced Glycated End products (AGEs) were generated due to glycation of protein and lipids
and these are significant markers of any degenerative disease in the body. Significantly (P=0.065
and P=0.025) increased levels of AOPPs and AGEs were observed in subjects (2.68±0.42 U/ml
and 133.36±31.65 mmol/L respectively) infected with OSCC as compared to healthy subjects
(0.85±0.04 U/ml and 83.05±6.63 mmol/L respectively).
4.2 INFLAMMATORY BIOMARKERS PROFILE OF ORAL CANCER PATIENTS Vs
CONTROL
The results of proinflammatory cytokines Interleukin-1α (IL-1α) and Tumor Necrosis
Factor-α (TNF-α) were shown in table 1. Results present in table 1 depicts that levels of IL-1α
significantly (P=0.032) increased (6.76±0.73 pg/ml) in Oral Cancer patients as compared to
healthy controls (5.68±0.53 pg/ml). Several interleukin were released in result of inflammation.
TNF-α is a significant cell signaling protein that release in case of inflammation and is a
significant stress marker. Results of present study showed that level of TNF-α significantly
(P=0.032) increased (32.72±3.12 pg/ml) in subjects as compared to healthy controls (29.57±1.22
pg/ml).
CHAPTER FOUR RESULTS
SAIMA, 2017
26
The mean value of IL-2, IL6, IL10, IL11, IL13, IL4 in control is 7.29±1.09, 2.99±0.08,
4.28±1.09, 4.29±1.08, 5.29±1.25 and 2.19±0.028 pg/ml respectively but the value of this
inflammatory markers was increased in diseased patients like 10.26±2.09, 4.26±1.09,
5.29±1.114, 8.28±2.19, 11.29±3.28 and 4.29±0.03 respectively. Hence, pointing towards an
increasing trend among oral cancer patients. A statistically highly significant result was observed
for ILs (p<0.05).
The mean value of MMP-1 and MMP-2 in controls is 42.29±11.29, 32.58±7.18 and that
of diseased patients is 98.26±14.56, 56.30±5.42 respectively. Therefore, a statistically increasing
trend was observed in oral cancer individuals (p-value=0.035 and p-value=0.023). In addition,
the mean value of MMP-13, MMP-9, MMP-11 and MMP-8 in healthy individuals is 53.26±5.26,
51.13±7.78, 45.60±9.67 and 56.29±4.28 but in oral cancer patients this value is increased to
76.29±7.59, 60.46±5.95, 65.46±4.16 and 144.29±15.25 respectively.
4.3 ANTIOXIDANT BIOMARKERS PROFILE OF ORAL CANCER PATIENTS Vs
CONTROL
The antioxidant biomarkers SOD, Catalase, vitamin E, vitamin C, vitamin D, vitamin A,
GPx, GRx and GSK3 beta are shown in table 1. In controls the mean value of SOD and catalase
was observed like 0.62±0.05 U/ml, 3.29±1.08 U/L but in diseased patients showed a mean value
was 0.32±0.05 U/ml and 0.40±0.04 respectively. An overall decreasing trend was observed in
SOD and catalase levels between OC patients and controls and its results was very significant
like (p-value=0.32 and p-value=0.22). Additionally, the mean value of GSH in controls and
patients is 7.56±2.16 mg/dl and 4.26±1.08 mg/dl respectively. An overall decreasing trend was
also observed in GSH levels between diseased patients and controls. The mean value of vitamin
A, C, E and D in controls is 62.08±4.91 nmol/L, 0.65±0.07 nmol/L, 0.19±0.06 nmol/L and
14.17±2.93 ng/ml respectively but in OC patients it values was decreased like 45.64±9.08
nmol/L, 0.42±0.01 nmol/L, 0.11±0.01 nmol/L and 10.11±1.13 ng/ml respectively. According to
the present study all these levels were significantly among healthy controls and patients having
P<0.05. Levels of GPx and GRx were also measured to evaluate the role of antioxidants in
patients infected with OSCC and results from table 1 describes that levels of GPx and GRx were
differs significantly in patients (1.59±0.29 and 7.30±1.19 µmol/L respectively) as compared to
healthy controls (6.50±0.47 and 3.09±1.28 µmol/L respectively). Levels of uric acid, iron and
copper for controls was found to be 4.26±1.06, 121.09±4.29 and 115.29±9.19 whereas in patients
CHAPTER FOUR RESULTS
SAIMA, 2017
27
diagnosed OSCC showed 1.09±0.01, 109.65±8.19 and 151.93±5.88 µg/dl respectively. Results
of present study were significantly different among healthy and controls (p<0.05).
TABLE: 01 LEVEL OF DIFFERENT VARIABLES AND THEIR INTERPLAY IN THE
DEVELOPMENT OF OSCC
VARIABLES CONTROL (n=100) SUBJECT (n=247) P- VALUE (0.05)
MDA nmoles/ml 1.36±0.38 3.87±1.10 0.016
Isoprostanes (pg/ml) 0.88±0.001 68.99±5.29 0.012
8-OHdG (pg/ml) 0.04±0.003 0.95±0.008 0.014
SOD (U/ml) 0.62±0.05 0.32±0.05 0.032
GSH (μmol/L) 7.56±2.16 4.26±1.08 0.012
CAT (U/L) 3.29±1.08 0.40±0.04 0.222
IL-1 (pg/ml) 5.68±0.53 6.76±0.73 0.032
IL-2 (pg/ml) 7.29±1.09 10.26±2.09 0.032
IL-6 (pg/ml) 2.99±0.08 4.26±1.09 0.012
IL-10 (pg/ml) 4.28±1.09 5.29±1.14 0.152
IL-11 (pg/ml) 4.29±1.08 8.28±2.19 0.011
IL-13 (pg/ml) 5.29±1.25 11.29±3.28 0.000
IL-4 (pg/ml) 2.19±0.02 4.29±0.03 0.016
TNF-α (pg/ml) 29.57±1.22 32.72±3.12 0.033
AOPPs (mmol/L) 83.05±6.6 133.36±3.65 0.025
AGEs (AU) 0.85±0.04 2.68±0.42 0.065
MMP-1 (ng/ml) 42.29±11.29 98.26±14.56 0.023
MMP-2 (ng/ml) 32.58±7.18 56.30±5.42 0.035
MMP-8 (ng/ml) 53.26±5.26 76.29±7.59 0.026
MMP-9 (ng/ml) 51.13±7.78 60.46±5.95 0.032
MMP-13 (ng/ml) 56.29±4.28 144.29±15.25 0.054
MMP-11 (ng/ml) 45.60±9.67 65.46±4.16 0.036
Vit-A (nmol/L) 62.08±4.91 45.64±9.08 0.011
Vit-C (nmol/L) 0.65±0.07 0.42±0.011 0.032
Vit-E (nmol/L) 0.19±0.06 0.11±0.018 0.041
Vit-D (ng/ml) 14.17±2.93 10.11±1.13 0.021
NO (μmol/L) 19.19±1.31 55.66±9.15 0.019
GPx (μmol/L) 1.59±0.29 6.50±0.47 0.032
GRx (μmol/L) 7.30±1.19 3.09±1.28 0.032
Uric Acid 4.26±1.06 1.09±0.018 0.032
Iron (µg/dl) 121.09±4.29 109.65±8.19 0.021
Cu(µg/dl) 115.29±9.19 151.93±5.88 0.032
GSK3 beta (GSK3B) ng/ml 75.29±8.26 33.26±4.19 0.000
CHAPTER FOUR RESULTS
SAIMA, 2017
28
FIGURE: 01 EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL IMPORTANCE AND THEIR
INTERPLAY IN THE DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA (OSCC)
0
1
2
3
4
5
6
Control Subject
MD
A (
nm
ole
s/m
l)
P=
0.0
16
0
10
20
30
40
50
60
70
80
Control Subject
Iso
pro
sta
nes
(p
g/m
l)
P=
0.0
12
0
0.2
0.4
0.6
0.8
1
1.2
Control Subject
8-O
hD
G (
pg
/ml)
P=
0.0
14
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
Control Subject
SO
D (
U/m
l)
P=
0.0
32
0
2
4
6
8
10
12
Control Subject
GS
H (
µm
ol/
L)
P=
0.0
12
0
1
2
3
4
5
Control Subject
CA
T (
U/L
)
P=
0.0
22
CHAPTER FOUR RESULTS
SAIMA, 2017
29
FIGURE: 02 EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL IMPORTANCE AND THEIR
INTERPLAY IN THE DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA (OSCC)
0
1
2
3
4
5
6
7
8
Control Subject
IL-1
(p
g/m
l)
P=
0.0
32
0
2
4
6
8
10
12
Control Subject
IL-2
(p
g/m
l)
P=
0.0
32
0
1
2
3
4
5
6
Control Subject
IL-6
(p
g/m
l)
P=
0.0
12
0
1
2
3
4
5
6
Control Subject
IL-1
0 (
pg
/ml)
P=
0.0
15
0
2
4
6
8
10
12
Control Subject
IL-1
1 (
pg
/ml)
P=
0.0
11
0
2
4
6
8
10
12
14
16
Control Subject
IL-1
3 (
pg
/ml)
P=
0.0
00
CHAPTER FOUR RESULTS
SAIMA, 2017
30
FIGURE: 03 EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL IMPORTANCE AND THEIR
INTERPLAY IN THE DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA (OSCC)
0
1
2
3
4
5
Control Subject
IL-4
(p
g/m
l)
P=
0.0
16
26
27
28
29
30
31
32
33
34
Control Subject
TN
F-α
(pg
/ml)
P=
0.0
33
0
20
40
60
80
100
120
140
160
180
Control Subject
AO
PP
s (m
mo
l/L
)
P=
0.0
25
0
0.5
1
1.5
2
2.5
3
3.5
Control Subject
AG
Es
(AU
)
P=
0.0
65
0
20
40
60
80
100
120
Control Subject
MM
P-1
(n
g/m
l)
P=
0.0
23
0
10
20
30
40
50
60
70
Control Subject
MM
P-2
(n
g/m
l)
P=
0.0
35
CHAPTER FOUR RESULTS
SAIMA, 2017
31
FIGURE: 04 EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL IMPORTANCE AND THEIR
INTERPLAY IN THE DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA (OSCC)
0
10
20
30
40
50
60
70
80
90
Control Subject
MM
P-8
(n
g/m
l)
P=
0.0
26
0
10
20
30
40
50
60
70
Control Subject
MM
P-9
(n
g/m
l)
P=
0.0
32
0
20
40
60
80
100
120
140
160
180
Control Subject
MM
P-1
3 (
ng
/ml)
P=
0.0
45
0
10
20
30
40
50
60
70
80
Control Subject
MM
P-1
1 (
ng
/ml)
P=
0.0
36
0
10
20
30
40
50
60
70
80
Control Subject
Vit
-A (
nm
ol/
L)
P=
0.0
11
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
Control Subject
Vit
-C (
nm
ol/
L)
P=
0.0
32
CHAPTER FOUR RESULTS
SAIMA, 2017
32
FIGURE: 05 EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL IMPORTANCE AND THEIR
INTERPLAY IN THE DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA (OSCC)
0
0.05
0.1
0.15
0.2
0.25
Control Subject
Vit
-E (
nm
ol/
L)
P=
0.0
41
0
2
4
6
8
10
12
14
16
18
Control Subject
Vit
-D (
ng
/ml)
P=
0.0
21
0
10
20
30
40
50
60
70
80
90
Control Subject
GS
K3
-β(n
g/m
l)
P=
0.0
00
0
10
20
30
40
50
60
70
Control Subject
NO
(µ
mo
l/L
)
P=
0.0
19
0
1
2
3
4
5
6
7
8
Control Subject
GP
x (
µm
ol/
L)
P=
0.0
32
0
1
2
3
4
5
6
7
8
9
Control Subject
GR
x (
µm
ol/
L)
P=
0.0
32
CHAPTER FOUR RESULTS
SAIMA, 2017
33
FIGURE: 06 EXPRESSION OF DIAGNOSTIC VARIABLES OF MEDICAL IMPORTANCE AND THEIR
INTERPLAY IN THE DEVELOPMENT OF ORAL SQUAMOUS CELL CARCINOMA (OSCC)
0
1
2
3
4
5
6
Control Subject
Uri
c A
cid
(m
g/d
l)
P=
0.0
32
95
100
105
110
115
120
125
130
Control Subject
Iro
n (
µg
/dl)
P=
0.0
21
CHAPTER FIVE DISCUSSION
SAIMA, 2017
34
DISCUSSION
CHAPTER FIVE DISCUSSION
SAIMA, 2017
35
5.0 DISCUSSION
Significant biomarkers play a key role in the diagnosis of various diseases. Inflammation
and oxidative stress are the major contributors in OSCC disease. Oxidative stress and
inflammatory markers such as MDA, ILs and MMPs have very high demand because they play
key role in the proliferation and is a prognostic variables in various diseases. Early diagnosis of
OSCC by these inflammatory and stress markers provides a new hopoe to overcome this disease
through different treatment regimes (Patton et al., 2008 and Mehrotra and Gupta, 2011). Oral
squamous cell carcinoma (OSCC), currently a global dilemma, is an aggressive malignant
disorder which is increasing at a threatening pace. It has become a serious lethal problem for
developing countries because of late diagnosis of this disease and have poor survival rate (Yi-
Shing and John, 2011). Oral cancer is a slow process that composed of metastasis and tumor
invasion, this disease results in inflammation and triggering angiogenesis. Carcinogenesis is
owing to the interaction between cancerous cells and cells in vicinity. The interplay of cytokines,
chemokines, interleukins, ROS, angiogenic factors and MMPs sets off OSCC. The oral
epithelium is bombarded with unlimited free radicals by the consistent use of tobacco, tobacco
related products and alcohol. Mitochondria, an ROS generating organelle, through the
mitochondrial respiratory chain and mitophagy, leads to the direct and indirect generation of
intermediates of reactive nitrogen (RNI) and reactive oxygen (ROI) under aerobic and hypoxic
conditions. Moreover it initiates hypoxia induced nitrative stress and fabricates lipid peroxidation
byproducts 4-hydroxynonenal (4-HNE) and malondialdehyde (MDA). In addition, inflammatory
cytokines, chemokines and processed proteins activate a wide range of transcription factors,
hence indirectly initiating oxidative stress. In OSCC both oxidative stress and inflammation
induce and trigger one another that result in more and more OSCC as shown in the figure 01.
Lipid peroxidation occurs because of oxidative stress, its markers such as MDA, 4-HNE,
Isoprostanes and 8OHdG describes the damage done to lipid membranes. This highly unstable
product of lipid peroxidation has also been known to form DNA-MDA adducts hence causing
collateral damage to the cellular DNA. A number of diseases have shown the presence of lipid
peroxidation as a key factor in their pathogenesis. Numerous studies on oral cancer individuals
have reported elevated MDA and lipid hydroperoxides (LHP) in blood, serum, saliva and tumor
samples. Present study showed a significantly increased MDA level in serum of oral cancer
patients as compared to healthy controls (Shetty et al., 2014 and Thomas and Sethupathy, 2015).
CHAPTER FIVE DISCUSSION
SAIMA, 2017
36
Results of present study describes that oral cancer release free radicals that induce cancer on the
other hand OSCC tumor itself participate in the generation of free radicals that leads to cause
decrease in antioxidants and results in lipid peroxidation. Results of present studies are similar
with the studies of Kurtul and Gokpinar, 2012; Agha-Hosseini et al., 2012; Srivastava et al.,
2012; Shilpasree et al., 2013; Ganesan and Kumar, 2014; Rasool et al., 2014; Metgud and Bajaj,
2014 and Malik et al., 2014). Nitric oxide is a key player in redox biology yet its unexplained
massive production or defective regulation has surfaced as contributors of cancer onset. The
multifaceted signaling molecule has both tumor promoting and tumor suppressive properties but
its function depends largely on when, where and in what quantity it is being produced. Deranged
levels of NO elicit various effects on the body which include direct and indirect effects.
Importantly, NO indirectly facilitates both oxidative and nitrosative stress. Also it facilitates
angiogenesis (Connelly et al., 2005 and Choudhari et al., 2012). Results of present study showed
significantly increased levels in oral squamous cell carcinoma patients as compared to controls
and this strongly suggests the massive production of NO from the reaction of L-arginine and
molecular oxygen and unchecked regulation of nitric oxide synthase (NOS) that facilitates this
reaction. It also points towards the fact that the more nitric oxide available, the more it will react
with superoxide ion or molecular oxygen to form peroxynitrite. Various inflammatory cells also
release NO in advanced stages of cancer and greater iNOS levels have also been reported in OC
patients. In addition, at one point the RNS peroxynitrite degrades into potential harmful products
known to interact with DNA. During long run, NO play key role in the induction nitrostative
stress, lipid peroxidation and NO mediated oxidative stress. Furthermore high concentration of
NO leads to induce high pain because NO induce several signaling pathways that leads to cause
activation of pain receptors. According to the results of present study it shows that NO has
significant relation in promoting tumor in oral cancer. Present study results were in accordance
with the studies of (Beevi et al., 2004; Bahar et al., 2007 Rasheed et al., 2007; Gokul et al., 2010
and Korde et al., 2011).
The novel OS marker AGES and AOPPs have emerged as key players in triggering OC.
Like lipids, cellular proteins are viable to free radical attacks during oxidative stress. Albumin
being the widely present protein is the most affected protein in the body. Primarily the
chlorinated oxidants, hypochlorous acid and chlorinated amines, are the products of
myeloperoxidase (MPO) system which cause protein damage resulting in generation of modified
CHAPTER FIVE DISCUSSION
SAIMA, 2017
37
proteins called AOPPs (Liu et al., 2006). In this study, significantly increased levels of advanced
oxidation of protein products (AOPPs) were found in patients as compared to controls. This
suggests that in patients myeloperoxidase system is relatively contributing to the formation of
huge amounts of hypochlorous acid. Excessive accumulation of this specific ROS causes it to
react with the most abundant protein albumin, oxidizing it to form AOPPs which further triggers
NADPH oxidase that leads to inflammation and oxidative stress. Results of present studies
showed that pateints diagnosed with oral cancer have high level of AOPPs as compared to
AGEs, it proves that AOPPs has major role in releasing inflammatory mediators in OC pateints.
Present results coincided with the study of (Barut et al., 2012).
Advanced glycation end products (AGEs) also provide strong evidence that it is involved
in the oxidative stress of the body. Sugars molecules that are present in the body show various
changes with time, during aging it generates potential compounds that combines with
biochemical compounds of the body and results in oxidative stress and inflammation in the body.
Lippid peroxidation will also release modified sugar through membrane of cell and proliferation
that have much poly unsaturated fatty acids (PUFA) (Kalousova et al., 2005). Levels of AGEs
were significantly high as compared to healthy controls. These results shows that lipid
peroxidation and oxidative stress are the major role player that induce damage to carbohydrates,
lipids and protein, that generates AGEs that results in inflammation. AGEs that are generated in
response of inflammation will activate NOx that leads to the activation of myeloperoxidase
(MPO) system. MPO cause release of OHOO that combines with protein albumin that
synthesize AOPPs. That’s why AGEs and AOPPs are the major factor to induce tumor in OSCC
patients. Other than AGEs and AOPPs, oral cancer can also proliferate due oxidative stress,
nitrative stress, nitrosative stress and lipid peroxidation. Nature has granted the cell with several
enzymatic and non-enzymatic antioxidants such as GPx, GRx, GSH, SOD, Vitamins A, C and E.
Several studies suggests that reduced activation of these antioxidants is the major reason behind
oral cancer.
SOD, a devourer of O2-, plays crucial role in preventing diseased states. This widely
present antioxidant in the body acts to convert highly reactive superoxide to molecular oxygen
and hydrogen peroxide so that the latter may be decomposed into less toxic and reactive
substances i.e water and molecular oxygen (Pham-Huy et al., 2008). Present study showed
significantly reduced levels in oral cancer patients as compared to healthy controls. Decreased
CHAPTER FIVE DISCUSSION
SAIMA, 2017
38
levels of SOD lead to the release of high levels of endogenous ROS in the body of patient those
results in generation of peroxynitrite by reaction of superoxide with NO. Present results were in
accordance with the studies of Manoharan et al., (2005), , Gupta et al., (2009), Gokul et al.,
(2010), Srivastava et al., (2012), Gurudath et al., (2012), Shilpasree et al., (2013), Shetty et al.,
(2013) Hegde et al., (2013), Vurumadla et al., (2014) and Thomas and Sethupathy (2015).
CAT enzyme involves in the conversion of ROS hydrogen peroxide in to water and
oxygen. In present study levels of CAT reduced singnificantly in subjects infected by oral cancer
as compared to healthy controls. These results show that CAT has negative correlation with
hydrogen peroxide that leads to induce oxidative stress in the body. Beevi et al. suggests that
catalase deficiency is might be due to high production of ROS from molecular oxygen and RNS.
Furthermore, it is to be suggested that free radicals may cause reduction in antioxidants such as
SOD and GPx that leads to decrease levels of catalase in OC patiens. Results of presents study
are resembles with the results of Manoharan et al, (1996); Kolanjiappan et al, (2003); Beevi et
al., (2004); Manoharan et al, (2005); Rasheed et al, (2007); Gokul et al, (2010); Srivastava et al,
(2012) and Thomas and Sethupathy, (2015)
The powerful antioxidant glutathione (GSH) is a resident of cytosol, peroxisomes and
mitochondria. In present study, the levels of GSH were greatly reduced in oral cancer patients
and these results coincided with the results of (Shivashankara and Prabhu, 2011; Srivastava et
al., 2012; Hegde et al., 2013; Shetty et al., 2013; Vurumadla et al., 2014 and Metgud and Bajaj,
2014 and Thomas and Sethupathy, 2015). Present results suggest that most of the GSH levels
may have been utilized to eliminate circulating oxidative stress causing free radicals (hydroxyl,
superoxide ion, hydrogen peroxide, lipid peroxides) or it may have been taken up by the tumor
itself as nutrition. Moreover, compromised state will generated due to decreased levels of GSH
that fails to produce antioxidants alpha-tocopherol and ascorbic acid in the body. Glutathione
peroxidase enzyme is a part of glutathione system. It catalyzes decomposition of hydrogen
peroxide (Khanna and Karjodkar, 2006 and Bathi et al., 2009). In present study levels of GPx
were increased in OSCC patients that suggest that levels of antioxidants such as SOD and CAT
were decreased in OC diagnosed patients. GPx plays a key role in reducing oxidative stress and
reduce hydrogen peroxide to molecule that is less toxic. Furthermore high activity of GPx will
converts GSH into oxidized form that leads to induce oxidative stress. Also it shows that
although the body is under attack of free radicals, it still manages to fight back by fueling its
CHAPTER FIVE DISCUSSION
SAIMA, 2017
39
antioxidant defense mechanism to counter-act the debilitating effects of free radicals. Present
results were in accordance with the studies of (Bagul et al., 2013).
GRx is the enzyme glutathione reductase that is involved in catalyzing oxidized form of
glutathione (GSSG) to its reduced form (GSH). Present study results showed decreased levels in
oral cancer which contradicts with the study results of (Fiaschi et al., 2005). Present results
revealed that reduced level of SOD, CAT and GSH and high level of GPx that release hydrogen
peroxide. This leads to the initiation of disturbance in the normal GSH to GSSG ration, that
cause increased GSSG levels as compared to GSH that puts pressure on GRx to generate more
GSH levels to overcome oxidative stress. During high ROS levels GRx tries to convert oxidized
GSH into reduced GSH but due to high level of ROS GRx levels gets reduced. Vitamin A,
originally stored in the liver, is considered a good antioxidant and apart from its various
functions, having a key role in normalizing immune system. Normally vitamin-A is synthesized
by macrophages and dendritic cells of mucosa and associated lymph nodes. CD4 T-cells were
converted into T-helper cell due to inflammation that leads to release of many pro inflammatory
cytokines (Green and Mellanby, 1928 and Raverdeau and Mills, 2014). In present study vitamin
A levels were found to be decreased in OC patients and this coincided with the results of
(Ramaswamy et al., 1990). Decreased level of Vit-C depicts that patients are mostly encounterd
with infection. Furthermore less amount of Vitamin-A will release proinflammatory cytokines
that will induce inflammation leading to oxidative stress through NADPH oxidase.
Vitamin E reduces the levels of hydroxyl radicals. Reducede level of vitamin-E also
induce inflammation in the body. Normal function of vitamin E is to minimize wound healing
time, maintaining the structure and function of membranes. Additionally, it plays role in
reversing premalignant lesions. Normal levels of vitamin E in the body prevent onset of disease.
It hinders cancer onset by stopping the growth of cancer cells and sending them to apoptotic
pathways. The release of cytotoxic cytokines causes apoptosis of these cancerous cells, hence
maintaining the equilibrium of normal and neoplastic cells. The results of present study show
reduced levels in oral cancer patients as compared to healthy controls. This implies that the
decreased levels are due to oral cancer, the tumor might have taken up antioxidants as nutrition.
These low levels also led to more accumulation of hydroxyl radicals, which in turn resulted in
more lipid peroxidation hence disturbing the cellular integrity and eventually leading to
enhanced chances of oral cancer development. Present results contradicted with the study of
CHAPTER FIVE DISCUSSION
SAIMA, 2017
40
Kolanjiappan et al. but were in accordance with the respective studies (Manoharan et al., 1996;
Manoharan and Nagini, 1996; ; Halliwell 1996 Subapriya et al., 2002; Kolanjiappan et al., 2003;
Manoharan et al., 2005; and Raghuwanshi et al., 2012).
The members of Toll/interleukin-1 receptor (TIR) family TLR1, TLR2, TLR4, TLR5
and TLR6 are found in plasma membrane and TLR 3, TLR7, TLR8 and TLR 9 reside in
intracellular compartments (Akira et al., 2001 and O'Neill et al., 2013). The cytoplasmic TIR
domain of TLR4 via IRAK4/TRAF6/IRAK1 activates NF-kB and MAPK signalling cascades,
producing inflammatory cytokines IL-6, IL-8, IL-1β and TNF-α (Vogl et al., 2007 and Kawai
and Akira, 2010). TLR9 through MyD88 pathway activates IRF-5, hence producing chemokine
IL-8 (Jozsef et al., 2006). TLR3 through adaptor molecule TRIF (TIR domain-containing
adaptor inducing interferon-β) activates various IRFs and release cytokines IFN alpha and beta.
While the remaining TLRs, through adaptor molecule MyD88 dependent pathway, activate a
myriad of intercellular signaling proteins resulting in activation of numerous transcription factors
hence initiating various signaling cascades. DAMPs and PAMPs, released by pathogens and
oxidative stress, are sensed by impeccable PRRs leading to activation of TLRs and NLRs. The
widely available TLRs give off reactive species at multiple stages containing mitochondrial,
activated NOX and transcription factor (IRF3, AP-1 and NF-κB) mediated liberation of
ROS/RNS. The cytosolic NLR by means of NLR/ASC/casp1 complex triggers release of
proinflammatory cytokines IL-18 and IL-1β. Additionally free radicals can hamper
inflammosome, shackling NLR signalling. Only TLR3 via adaptor molecule TRIF activates
IRF3 and IRF7, eventually generating cytokines. While the remaining MyD88-dependent TLRs
activate myriad intercellular signaling proteins and numerous transcription factors, triggering
various signaling cascades and finally directing the release of inflammatory cytokines,
chemokines, gelatinases or marking the cell for apoptosis.
The crucial pro-inflammatory cytokine 1L-1alpha is detectable in both normal and
dysregulated inflammatory processes. It is one of the earliest cytokines to be released by
inflammatory cells at the slightest sign of inflammation. IL-1α shows both beneficial and
harmful effects in the body normal amount of IL-1α is involved in healing of wounds and tissue
repair but in diseased case this cytokines induce several chronic diseases (Chedid et al., 1994;
Hubner et al., 1996 and Margioris 2009). Present study results showed significantly increased
levels of this cytokine in oral cancer patients, implying that deregulated inflammation is present
CHAPTER FIVE DISCUSSION
SAIMA, 2017
41
in OSCC. Present results shows that a large amount of cytokines been released by inflammatory
cell such as fibroblast, neutrophils and macrophages that were activated by tobacco, alcohol or
stress. That’s why IL-1α plays a key role in causing tumor progression and metastasis during
OSCC. In present patients enhanced oxidative stress led to activation of this cytokine. Present
study results coincided with the study of Rhodus et al. 2005 and Saheb-Jamee et al. 2008. Tumor
necrosis factor-alpha (TNF-α) is a specific cytokine that can initiate various signaling pathway
and having pro-angiogenic and pro-inflammatory functions. The cells releasing this cytokine are
involved in myriad functions of the cell including immunity, inflammation and defense against
infection. Moreover it has role in anti-inflammatory and immunoregulatory activities. It shows
its response in each stage of carcinogenesis. TNF-α is an angiogenesis regulator and is a
promoter of tumor formation, having tumor necrotic and tumor promoting activities in the body.
This multifunctional cytokine controls inflammatory cell populations and also mediates many
aspects of inflammatory process. Controversial levels of TNF-α have been reported in oral
cancer patients. These results were in accordance with the study of Krishnan et al., Jablonska et
al., Kurokawa et al., Nakano et al., Saheb Jamee et al., Rhodus et al., and Brailo et al.
(Jablonska et al., 1997; Kurokawa et al., 1998; Nakano et al., 1999; Rhodus et al., 2005; Brailo
et al., 2006; Saheb Jamee et al., 2008 and Krishnan et al., 2014). Present results imply that this
cytokine has role in oral cancer prognosis. It is taking part in inflammatory responses and
promoting angiogenesis.
The tumor microenvironment comprises of cancer cells and associated stromal
components. In OSCC, activated MMP-9 released from cancer cells and inflammatory cells
through CD44 degrades ECM. Meanwhile activated MMP-2 released from Carcinoma-
associated fibroblasts (CAFs) via αVβ6 pathway up regulates MMP-9. Both gelatinases break
down ECM, assist tumor invasion and release inflammatory markers. Release of MMPs,
cytokines, chemokines and ROS will activate various transcription factors that leads to the start
of signaling cascade. OSCC progression occurs through a cascade of angiogenesis followed by
EMT that were activated by growth factors. The action of gelatinase B as pro-angiogenic and
anti-angiogenic regulates the crucial step of angiogenesis. MMPs are good biomarkers of oral
squamous cell carcinoma as reported by Wonga et al. (Wonga et al., 2014). The role of various
MMPs as ECM digesters has been known in different diseases. MMP-11, also known as
stromelysin-3, does not cleave the extracellular matrix but it is suspected to have a unique role in
CHAPTER FIVE DISCUSSION
SAIMA, 2017
42
tumor development and progression. Elevated levels of MMP 11 have been seen in most human
cancers. Importantly, MMP 11 is processed intracellularly and secreted as an active enzyme.
Present results show increased levels of MMP 11 in oral cancer patients; this result contradicts
with the study of Hsin et al. but coincides with the results of (Soni et al., 2003 and Arora et al.,
2005 and Hsin et al., 2014). The increased levels of MMP 11 throw light on the fact that that
carcinoma associated fibroblasts have MMP 11 reserves in them. As CAFs have unique role in
OSCC, therefore these specialized cells are involved in the release of MMP 11 in oral cancer. In
addition, these increased levels leads to conversion from precancerous to malignant form.
Gelatinases are secreted as inactive enzymes which can be effective only after activation.
On the other hand MMP 11 does not need to be activated by certain enzymes. MMP 2 and MMP
9 degrade the extracellular matrix. Present study results show that gelatinases were elevated in
oral cancer patients as compared to controls, this matched with the study of (Ikebe et al., 1999;
Kato et al., 2005 and Lee et al., 2008 and Katayama et al., 2004). Importantly, the levels of
MMP 9 were found to be more enhanced than the levels of MMP 2 in OC patients. This
coincided with the study of (Mishev et al., 2014). Increased level of MMP-9 in OC patients
shows its important role in proliferation of cancer; this is similar with the study of Ravi et al.,
2014. Increased level of MMP shows that rather it get over expressed by cancerous cell or
increase release of inflammatory cytokines that trigger their production from host stromal cells.
Additionally the more secreted levels of gelatinases, the more ECM degradation will occur hence
leading towards tumor invasion and angiogenesis.
The study results show a strong positive correlation of MDA with CAT (r= 0.460**, p=
0.001) and NO (r=0.453**, p=0.001). SOD showed a strong positive correlation with vitamin E
(r=0.283*, p=0.046), MMP 9 (r=0.462**, p=0.00), MMP11 (r=0.356, p=0.011), GPx (r=0.413**,
p=0.003) and GRx (r=0.285, p=0.045) whereas an inverse relation of SOD with GSH (r=-0.320*,
p=0.024) was observed. GSH showed a strong postive correlation with catalase (r=0.536**,
p=0.000) and TNF-α (r=0.297*, p= 0.036) whereas an inverse correlation of GSH exists with
vitamin E (r=-0.281*, p= 0.048) and MMP-9 (r=-0.422**, p= 0.002). Catalase showed a strong
positive correlation with MMP 9 (r=-0.284, p= 0.045). The cytokine IL-1α showed a positive
correlation with MMP 2 (r=0.323*, p=0.022). GPx showed a strong positive correlation with
MMP 9 (r=0.311*, p= 0.028). In addition AGEs showed a strong positive correlation with MMP
2 (r= -0.306*, p= 0.03) and MMP 9 showed a positive correlation with MMP 11 (r= 0.415**, p=
CHAPTER FIVE DISCUSSION
SAIMA, 2017
43
0.003). All these parameters have a direct correlation with each other (p<0.05) except SOD vs.
GSH, GSH vs. Vit. E, GSH vs. MMP 9, Cat vs. MMP 9 and AGEs vs. MMP 2 which has an
inverse correlation (p>0.05). Moreover all values were found to be statistically significant.
Additionally MDA vs. CAT, MDA vs. NO, SOD vs. GPx, SOD vs. MMP 9 and GSH vs. CAT
showed highly significant levels (p<0.01).
CHAPTER FIVE DISCUSSION
SAIMA, 2017
44
CHAPTER FIVE DISCUSSION
SAIMA, 2017
45
FIGURE 07: PATHWAY INVOLVED IN PATHOGENESIS OF (OSCC). The inhibition of apoptosis is the hallmark of oral cancer pathogenesis which is controlled by several mitochondrial
(intrinsic) or by activation of pro-Caspase 8 (extrinsic) pathways. Higher levels of Bcl-2 (anti-apoptotic protein) and lower level of Bax (apoptotic protein) are frequently reported in oral cancer. The
expression of Bcl-2 in OSCC cell lines is affected by minor alterations in the status of pSer9GSK3β. Active GSK3β blocks CREB dependent expression of Bcl-2 (anti-apoptotic protein). The
increase in the expression of Bax protein is regulated by p53 activity resulting in the initiation of apoptosis. But the modulation of several therapeutic molecules like GSK3β and other active
apoptotic proteins increase p53 dependent activation of Bax resulting in the release of cytochrome C from the mitochondrial matrix causing loss of mitochondrial membrane potential and progression
of Caspase 9. Protein kinase A has been identified as the therapeutic target in OSCC because it affects the signaling of many molecules e.g NF-kβ, Cyclin D1, Bcl-2, COX-2 & p21 resulting in the
onset of OSCC. PI3K/Akt pathway has been known to play a significant role in oral squamous cell carcinoma initiation. pSer9GSK3β (oncogenic protein) level in OSCC cell lines is very high and
can be blocked by inhibiting Akt signaling. Protein Kinase C signaling also suggests its role in oral cancer progression as the inhibition of PKC reduces MMP-2, MMP-9 & COX-2. Suppression of
PKC activity promotes Akt signaling which increases apoptosis of epithelial cells. Therefore targeting of PKC has shown promising results in decreasing the invasion and mortality of OSCC cell
lines. Moreover p90RSK has also been studied for its role in epithelial cell motility and invasiveness. Tumor promoting phorbol esters inhibit p70RSK by activating p90RSK (MAPKAP-K1) might
promote oral cancer. GSK3β regulated c-Myc is the master regulator of cell cycle essential for the progression of G0/ G1 to S phase. C-Myc also activates cyclin D1,E1 and A2, CDK4, CDC25A and
E2F-1 and 2.Cyclin D1 is a crucial cell cycle regulator mainly regulated by NK-kβ, β-catanin-TCF/LEF, AP1. But the inactivation of above said oncogenic regulators leads to the stabilization of
Cyclin D1. Oncogenic gains of function of these anti-apoptotic molecules have been established to deregulate cell cycle in OSCC. Normal epithelial cells are connected to each other by E-cadherin
which in turn connects to the actin cytoskeleton. Epithelial mesenchymal transition (EMT) is caused by decreased level of E-cadherin, which is suppressed by snail. MMPs and COX-2 degrade the
intact basement membrane and facilitate the migration of cancer cells. These upregulated MMPs, MDA, IL-2,6 & COX-2 are controlled by various anti-inflammatory biomarkers NF-kβ, AP1, α/ β
integrin and various antioxidants such as Vitamin C ,Vitamin E, GSH, SOD and Catalase, which maintain the balance between proliferation and death resulting in tissue homeostasis in normal
epithelium which might be disturbed in OSCC.
CHAPTER FIVE DISCUSSION
SAIMA, 2017
46
TABLE 02: PEARSON CORRELATION (TWO-TAILED) IN ORAL SQUAMOUS CELL CARCINOMA (OSCC)
VAR. MDA SOD GSH CAT VIT.E NO IL-1α TNFα GPx GRr AGEs AOPPs VIT- A MMP2 MMP9 MMP11 8-OHdG IL-6 GSK3β Uric Acid
MDA 1
-0.132
0.362
0.236
0.099
0.460**
0.001
0.045
0.758
0.453**
0.001
-0.008
0.959
0.082
0.572
-0.012
0.935
-0.008
0.957
-0.229
0.109
-0.047
0.745
-0.032
0.824
0.019
0.894
-0.164
0.254
-0.084
0.562
0.826
0.00
0.629
0.031
-0.509
0.01
-0.659
0.016
SOD 1 -0.320*
0.024
-0.045
0.755
0.283*
0.046
0.193
0.180
0.020
0.892
-0.106
0.464
0.413**
0.003
0.285*
0.045
0.066
0.648
-0.020
0.889
0.070
0.630
-0.210
0.143
0.462**
0.001
0.356*
0.011
-0.623
0.02
-0.549
0.019
0.629
0.03
0.561
0.031
GSH 1
0.536**
0.000
-0.281*
0.048
-0.263
0.065
0.081
0.578
0.297*
0.036
-0.195
0.176
-0.219
0.127
0.035
0.811
0.028
0.847
-0.017
0.908
0.114
0.430
-0.422**
0.002
-0.189
0.188
0.426
0.03
-0.619
0.043
0.406
0.016
0.465
0.015
CAT 1
0.022
0.880
0.081
0.575
-0.057
0.696
0.263
0.065
-0.101
0.487
-0.116
0.421
0.016
0.914
0.078
0.592
-0.139
0.337
-0.056
0.700
-0.284*
0.045
-0.128
0.377
0.426
0.05
-0.459
0.014
0.506
0.001
0.629
0.001
VIT.E 1 0.217
0.130
-0.109
0.452
-0.072
0.661
0.258
0.070
0.093
0.522
0.024
0.868
-0.242
0.091
-0.136
0.345
-0.162
0.261
-0.022
0.882
-0.019
0.896
0.626
0.06
-0.455
0.06
0.406
0.06
0.265
0.56
NO 1 -0.176
0.222
-0.161
0.264
0.180
0.211
0.030
0.836
-0.093
0.520
-0.133
0.356
-0.151
0.296
-0.140
0.333
0.078
0.591
-0.119
0.409
0.406
0.15
0.629
0.04
0.619
0.04
-0.569
0.015
IL-1 1 -0.003
0.986
-0.026
0.860
-0.253
0.076
0.135
0.350
0.092
0.524
0.179
0.213
0.323*
0.022
0.091
0.531
0.226
0.114
0.826
0.00
0.466
0.056
-0.628
0.016
-0.626
0.056
TNFα 1 -0.221
0.171
0.138
0.394
-0.062
0.703
-0.063
0.701
0.149
0.357
-0.112
0.491
0.232
0.149
0.302
0.058
7.59
0.04
0.629
0.016
-0.826
0.00
-0.765
0.016
GPx 1 0.263
0.065
0.052
0.721
-0.119
0.411
0.223
0.119
-0.169
0.242
0.311*
0.028
0.195
0.174
-0.619
0.03
-0.529
0.264
0.529
0.16
0.658
0.01
GRr 1 -0.057
0.692
0.053
0.715
-0.015
0.918
0.074
0.608
0.195
0.175
0.179
0.214
-0.526
0.01
-0.426
0.01
0.496
0.16
0.465
0.016
AGEs 1 0.127
0.379
0.035
0.808
-0.306*
0.030
0.078
0.589
-0.055
0.704
0.666
0.028
0.426
0.03
-0.495
0.017
-0.165
0.016
AOPPs 1 0.062
0.671
0.083
0.566
0.256
0.072
-0.139
0.336
0.529
0.01
0.526
0.019
-0.165
0.010
-0.426
0.014
VIT.A 1 0.009
0.950
0.025
0.864
0.109
0.450
-0.459
0.05
-0.659
0.016
0.659
0.003
-0.658
0.010
MMP2 1 -0.255
0.074
-0.080
0.582
0.729
0.00
0.806
0.04
-0.659
0.00
-0.659
0.00
MMP9 1 0.415**
0.003
0.816
0.01
0.629
0.016
-0.745
0.019
-0.689
0.018
MMP11 1 0.629
0.011
-0.726
0.016
-0.881
0.001
-0.776
0.000
8-OHdG 1 0.916
0.016
-0.629
0.016
0.666
0.048
IL-6 1 -0.629
0.003
-0.465
0.011
GSK3β 1 0.649
0.04
Uric
Acid
1
CHAPTER SIX SUMMARY
SAIMA, 2017
47
SUMMARY
CHAPTER SIX SUMMARY
SAIMA, 2017
48
6.0 SUMMARY
The most common type of oral cancer is known as OSCC (Oral Squamous Cell
Carcinoma) which is essentially involved in affecting tongue and floor of oral cavity. Apart from
the fact that its detection in early stages remains challenging as it is an asymptomatic
complication whereas, it can be later symptomized by the pain lasting for more than two weeks
and development of lymph node metastasis in later stages. It contributes in worldwide elaborated
rates of mortality and morbidity. In Asian subcontinent especially in countries such as India and
Pakistan the rate of OSCC are significantly higher due to higher rate of people belonging to
socioeconomically statuses and increased number of people habitual of betel quid. Other myriad
factors of OSCC includes family history, cannabis, excessive use of tobacco and tobacco
products, regular alcohol intake, narcotics and antioxidant deficient diet. Moreover Hepatitis C,
Herpes virus, Candida albicans, Human immunodeficiency virus, Human papilloma virus and
Epstein Barr viruses have also been considered potential causative factors. In the recent years
burgeon of OSCC cases has been reported in individuals less than 45 years specifically from 18
to 44 years. It has been observed that younger people especially males are more prone to develop
OSCC than females due to excessive use of tobacco and tobacco associated products. Both
smokers and alcoholics have a six fold risk of oral neoplasm than non-smokers and non-
alcoholics whereas those individuals practicing both habits have a fifteen fold risk of OSCC than
healthy individuals. By and large tobacco and alcohol in the West, gutka and betel quid in
Taiwanese, Maras powder in Turks, betel quid in Asians and in Indians areca nut, tobacco, and
betel quid along with alcohol consumption account for the onset of OSCC.
Conventionally imaging techniques followed by blood, serum and biopsy samples are
used for OSCC detection but in the recent years the distinguished role of saliva as a diagnostic
tool has been widely accepted. Usually surgery followed by radiotherapy is the prime treatment
in OSCC stages I and II whereas for stages III and IV a combination of surgery, radiotherapy and
chemotherapy is utilized. Likewise immunotherapy, gene therapy, altered fractionated
radiotherapy; cervical lymph adenectomy, selective neck dissection, concomitant chemo-
radiotherapy (CT-RT) and targeted molecular therapy are also novel prospective treatments.
Globally, a notable reason behind the drastic boom in OSSC cases is that the masses are not fully
cognizant of the hazardous effects of tobacco products and alcohol. In order to get rid of this
social taboo, a substantial number of awareness programs should be arranged to enlighten the
CHAPTER SIX SUMMARY
SAIMA, 2017
49
public about the debilitating effects of tobacco chewing, tobacco smoking, alcohol consumption
and excessive use of tobacco related products. The government can contribute by taking strict
steps on multiple levels to ban the sale and use of these noxious products. Likewise emphasis on
preventive measures such as opting for early screening, avoiding unnecessary irradiation and
consuming diet rich in iron and antioxidants can promise an oral cancer free life.
These zinc dependent endopeptidases are produced according to the cell's need by wound
cells as well as inflammatory cells and are known to play essential roles in both normal and
diseased state. Under normal conditions, MMPs are secreted in very low amounts and they are
involved in tissue remodeling processes like ossification, placenta development, and embryonic
development and wound healing. On the basis of substrate specificity, sequence similarity and
domain organization metalloproteinases are categorized as: collagenases, gelatinases,
stromelysins, matrilysins and membrane type MMPs (MT-MMPs). Generally all MMPs consist
of a signal peptide, a pro-peptide having highly conserved Cysteine residues, a zinc containing
catalytic domain and a hemopexin like domain which is attached to the catalytic domain by a
linker. But the striking feature that separates gelatinases from other MMPs is the presence of a
fibronectin type II like domain. One of the characteristic marks in cancer invasion is the
deterioration of extracellular matrix (ECM) which is efficiently done by matrix
metalloproteinases (MMPs).
Myriad MMPs (MMP 1, 2, 3, 7, 9, 11, 13 etc.) take part in OSCC disease progression
but the crucial role of gelatinases has been widely established. It has been observed that in OSCC
the HIF-1α is upregulated which is the reason behind elevated levels of gelatinases and hence
decreased prognosis. MMP-9 has a dual role in angiogenesis where it may act as angiogenic or
anti-angiogenic depending on the situation. Various growth factors play essential roles in the first
step of tumorigenesis. For instance overexpression of TGF-β1 is responsible for spiked
expression of MMP-9 in OSCC studies. It has been discovered that Snail, the transcription
factor, aids in elevating MMP-9 expressions. Sufficient data supports the versatile role of
gelatinases in oral squamous cell carcinoma. Gelatinase B (MMP-9) has a significant role in
OSCC progression and its expression along with activity has been thoroughly weighed. MMP-9
has vital role in metastasis. In addition, ethanol has been found to positively affect expression of
gelatinases. It is found that increased expression of MMP-9 is majorly associated with
metastasis. Yet studies show that increased expression of both gelatinase A and B in OSCC was
CHAPTER SIX SUMMARY
SAIMA, 2017
50
in correlation with only tumor invasiveness. Likewise another set of investigation suggests that
the association of gelatinases with different tumor stages and concluded that MMP 9 levels were
elevated in OSCC but the active form of MMP 9 was less in quantity as compared to the levels
of activated MMP 2, hence MMP 2 has correlation with advanced stages. Mukherjee et al.
showed that gelatinases are highly involved in cancer and pre-cancer states. Apart from this,
scientists found that gelatinolytic activity in OSCC is due to activated 72 kD gelatinase A. In a
different study moderate expression of MMP-2 was seen while MMP-9 levels were the highest.
Another investigative study discovered that it is the increased gelatinases in OSCC
patients that leads to their low survival rates. Enhanced amounts of these metalloproteases
pinpoints the fact that greater levels are owing to either the over expression of MMPs by
cancerous cells or the increased inflammatory cytokine expression may have triggered their
production from the host stromal cells. Additionally the more secreted levels of gelatinases, the
more ECM degradation will occur hence leading towards tumor invasion and angiogenesis.
CHAPTER SEVEN CONCLUSION
SAIMA, 2017
51
CONCLUSION
CHAPTER SEVEN CONCLUSION
SAIMA, 2017
52
7.0 CONCLUSION
Oral squamous cell carcinoma (OSCC) is a modern day catastrophe affecting millions of people
around the globe, including Pakistan. It has gained worldwide attention owing to low survival rates, late
detection, poor prognosis, and escalated mortality rates. Aside from tobacco, tobacco products and
alcohol there are myriad potential factors which contribute to etiopathogenesis of OSCC. Oral cancer
affects men more than women as the former are more habitual users of notorious tobacco and tobacco
products. Currently, the search for predictive OSCC biomarkers is in demand to maximize survival rates.
The present study was done to evaluate the oxidant-antioxidant status and inflammatory profile in oral
cancer subjects. Present research work provides strong evidence that oral cancer patients presented
elevated oxidative stress, enhanced inflammation and reduced antioxidant enzymes in their serum as
compared to their healthy counterparts. Therefore the study strongly approves that MMPs, inflammatory
and lipoxidative biomarkers hold promise for their predictive potential in OSCC. Moreover the
implication of antioxidant therapy during early stages, serves as new potential to overcome OSCC. Lastly,
the understanding of potential role of these certain biomarkers calls for their ultimate utilization and
implementation as prognostic and predictive OSCC biomarkers.
LITERATURE CITED
SAIMA, 2017
53
LITERATURE CITED
LITERATURE CITED
SAIMA, 2017
54
LITERATURE CITED
Abbasi MM, R Jahanban-Esfahlan, A Monfaredan, K Seidi, H Hamishehkar and MM Khiavi
(2014). Oral and IV dosages of Doxorubicin-Methotrexate loaded-nanoparticles inhibit
progression of oral cancer by down regulation of matrix metalloproteinase 2 expression
in vivo. Asian Pac J Cancer Prev. 15(24):10705-10711.
Aebi H (1974). Catalase. In: Bergmeyer HU (ed). Methods in enzymatic analysis. New York,
Academic Press. 3:276-286.
Aebi HI and HU Bergmeyer (1974). Methods of enzymatic analysis. Academic Press, New
York 2:674-84.
Aggarwal BB, R Vijayalekshmi and B Sung (2009). Targeting inflammatory pathways for
prevention and therapy of cancer: short-term friend, long-term foe. Clinical cancer
research. 15:425-430.
Agha-Hosseini F, I Mirzaii-Dizgah, N Farmanbar and M Abdollahi (2012). Oxidative stress
status and DNA damage in saliva of human subjects with oral lichen planus and oral
squamous cell carcinoma. J Oral Pathology Med. 41:736-740.
Aimes R and J Quigley (1995). Matrix metalloproteinase-2 is an interstial collagenase. J. Biol.
Chem. 270:5872-5876.
Akira S, K Takeda and T Kaisho (2001). Toll-like receptors: critical proteins linking innate and
acquired immunity. Nat Immunol. 2:675-80.
Albano PM, C Lumang-Salvador, J Orosa, S Racelis, M Leano, LM Angeles and JD Ramos
(2013). Overall survival of Filipino patients with squamous cell carcinoma of the head
and neck: a single-institution experience. Asian Pac J Cancer Prev. 14(8):4769-4774.
Anderson ME (1998). Glutathione: an overview of bio synthesis and modulation. Chem Biol
Interact. 111-112:1-14.
Anonymous (2012). Signosis, Inc. 528 Weddell Drive, Suite 5, Sunnyvale, CA 94089.
Arellano-Garcia ME, S Hu, J Wang, B Henson, H Zhou, D Chia and DT Wong (2008).
Multiplexed immunobeadbased assay for detection of oral cancer protein biomarkers in
saliva. Oral Dis. 14(8):705–12.
Arora S, J Kaur, C Sharma, M Mathur, S Bahadur et al. (2005). Stromelysin-3, Ets-1, and
vascular endothelial growth factor expression in oral precancerous and cancerous
LITERATURE CITED
SAIMA, 2017
55
lesions: correlation with micro vessel density, progression and prognosis. Clin Cancer
Res. 11:2272-2284.
Arribas J, L Coodly, P Vollmer, TK Kishimoto, S Rose-John and J Massague (1996). J. Biol.
Chem. 271:11376-11382.
Astekar M, R Metgud, A Sharma and A Soni (2013). Hidden keys in stroma: Unlocking the
tumor progression. J Oral Maxillofac Pathol. 17:82-8.
Attar E, S Dey, A Hablas, IA Seifeldin, M Ramadan, LS Rozek and AS Soliman (2010). Head
and neck cancer in a developing country: A population-based perspective across 8 years.
Oral Oncol. 46(8):591-596.
Ayala A, MF Munoz and S Arguelles (2014). Lipid peroxidation: Production, Metabolism, and
signaling mechanisms of malondialdehyde and 4-Hydroxy-2-Nonenal. Oxidative
medicine and cellular longevity. 31
Backstrom JR, GP Lim, MJ Cullen and ZA Tokes (1996). Matrix metalloproteinase-9 (MMP-9)
is synthesized in neurons of the hippocampus and is capable of degrading the amyloid-β
peptide (1-40). J. Neurosci. 16(24):7910-7919.
Bagan J, G Sarrion and Y Jimenez (2010). Oral cancer: clinical features. Oral Oncol. 46(6):414-
417.
Bagul N, A Ganjre, S Kheur, D Patekar, S Dasgupta and A Mahalle (2013). Serum levels of
antioxidant in patients with oral squamous cell carcinoma: a preliminary study. IOSR-
JDMS. 11(5):28-32.
Bahar G, R Feinmesser, T Shpitzer, A Popovtzer and RM Mahler (2007). Salivary analysis in
oral cancer patients. Cancer. 109(1):54-59.
Bannikov GA, TV Karelina, IE Collier, BL Marmer and GI Goldberg (2002). Substrate binding
of gelatinase B induces its enzymatic activity in the presence of intact pro peptide.
Journal of Biological Chemistry. 277(18):16022-16027.
Bano S, MP David and AP Indira (2015). Salivary biomarkers for oral squamous cell carcinoma:
An overview. IJSS case reports & reviews. 1(8):39-45.
Bansal M, S Vashisth, N Gupta and S Singh (2012). Antioxidants- Its preventive role in oral
cancer. Indian Journal of Dental Sciences. 3(4):103-105.
LITERATURE CITED
SAIMA, 2017
56
Barbosa E, J Faintuch, EAM Moreira et al. (2009). Supplementation of vitamin E, vitamin C,
and zinc attenuates oxidative stress in burned children: a randomized, double-blind,
placebo-controlled pilot study. J Burn Care Res. 30(5):859-866.
Barnes L, JW Everson, PA Reichart and D Sidransky (2005). World Health Organization
classification of tumours: pathology and genetics of oral tumors. IARC Press, Lyon.
168-174.
Bartsch H and J Nair (2006). Chronic inflammation and oxidative stress in the genesis and
perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Lange
neck’s Archives of Surgery. 391(5):499-510.
Barut O, P Vural, S Sirin, S Aydin and Y Dizdar (2012). The oxidant/antioxidant status and cell
death mode in oral squamous cell carcinoma. Acta Odontologica Scandinavica.
70(4):303-308.
Baskaran S, S Lakshmi and PR Prasad (1999). Effect of cigarette smoke on lipid peroxidation
and anti-oxidant enzymes in albino rat. Ind J Exp Biology. 37(12):196-200.
Bathi RJ, R Rao and S Mutalik (2009). GST null genotype and antioxidants: risk indicators for
oral pre-cancer and cancer. Indian Journal of Dental Research. 20(3):298-303.
Baykara M, S Buyukberber, B Ozturk, U Coskun, DK Unsal, U Demirci, F Dane, MA Kaplan, H
Bora and M Benekli (2013). Efficacy and safety of concomitant chemoradiotherapy with
cisplatin and docetaxel in patients with locally advanced squamous cell head and neck
cancers. Asian Pac J Cancer Prev. 14(4):2557-2561.
Beenken SW and MM Urist (2003). Oral tumors. In: l.W Way and G.M. Doherty, editors,
Current surgical diagnosis and treatment (11th ed.), Lange Medical Books/ McGraw-
Hill, New York. 282-229.
Beevi SS, AM Rasheed and A Geetha (2004). Evaluation of oxidative stress and nitric oxide
levels in patients with oral cavity cancer. Jpn J Clin Oncol. 34(7):379-385.
Bektaş-Kayhan K (2012). Role of Inflammation in Oral Squamous Cell Carcinoma, Squamous
Cell Carcinoma, Prof. Xiaoming Li (Ed.), ISBN: 978-953-51-0024-9, InTech, 195-212.
Bell RB, D Kademani, L Homer, EJ Dierks and BE Potter (2007). Tongue cancer: Is there a
difference on survival compared with other subsites in the oral cavity? J Oral Maxillofac
Surg. 65(2):229-236.
LITERATURE CITED
SAIMA, 2017
57
Bello IO, Y Soini and T Salo (2010). Prognostic evaluation of oral tongue cancer: means,
markers and perspectives (I). Oral Oncol. 46(9):630-635.
Berg JM, JL Tymoczko and L Stryer (2002). Biochemistry. WH Freeman, New York, NY, USA,
5th edition.
Bergers G, R Brekken, G McMahon, TH Vu, T Itoh, K Tamaki, K Tanzawa, P Thorpe, S Itohara,
Z Werb and D Hanahan (2000). Matrix metalloproteinase-9 triggers the angiogenic
switch during carcinogenesis. Nature Cell Biology 2(10):747-744.
Bhuvaneswari P (2014). Antioxidants in oral healthcare. J. Pharm. Sci. & Res. 6(4):206-209.
Bjorklund M and E Koivunen (2005). Gelatinase-mediated migration and invasion of cancer
cells. Biochim Biophys Acta. 1755(1):37-69.
Bogdanovic V, S Tursijan, M Dordevic, A Nikolic, J Mrdanovic, D Jakimov et al. (2008).
Activity of lactate dehydrogenase and superoxide dismutase in the circulation of patients
with breast carcinoma. Arch Oncol. 16(3-4):39-41.
Brailo V, V Vucicevic-Boras, A Cekic-Arambasin et al. (2006). The significance of salivary
interleukin 6 and TNF-α in patients with oral leukoplakia. Oral oncol. 42:370-3.
Brandwein-Gensler M, MS Teixeira, CM Lewis, B Lee, L Rolnitzky, JJ Hille, E Genden, ML
Urken and BY Wang (2005). Oral squamous cell carcinoma: histologic risk assessment,
but not margin status, is strongly predictive of local disease-free and overall survival.
Am J Surg Pathol. 29(2):167-178.
Bredt DS and SH Snyder (1994). Transient nitric oxide synthase neurons in embryonic cerebral
cortical plate, sensory ganglia, and olfactory epithelium.neuron. 13(2):301-13.
Brinkmann O, DA Kastratovic, MV Dimitrijevic, VS Konstantinovic, DB Jelovac, J Antic, VS
Medic, SZ Markovic, ZR Martinovic, D Akin, N Spielmann, H Zhou and DT Wong
(2011). Oral squamous cell carcinoma detection by salivary biomarkers in a Serbian
population. Oral Oncol. 47(1):51-5.
Butler GS and CM Overall (2009). Updated biological roles for matrix metalloproteinases and
new "intracellular" substrates revealed by degradomics. Biochemistry. 48(46):10830-
10845.
Butler GS, SS Apte, F Willenbrock and G Murphy (1999). Human tissue inhibitor of
metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A
LITERATURE CITED
SAIMA, 2017
58
and B: regulation by polyanions. Journal of Biological Chemistry. 274(16):10846-
10851.
Cerutti PA (1994). Oxy-radicals and cancer. Lancet. 344:862-863.
Chandler S, R Coates, A Gearing, J Lury, G Wells and E Bone (1995). Matrix metalloproteinases
degrade myelin basic protein. Neurosci. Lett. 201(3):223-6.
Chapple IL and JB Matthews (2000). The role of reactive oxygen and antioxidant species in
periodontal tissue destruction. Periodontol 2000. 43:160-232.
Chaudhary M, S Bajaj, S Bohra, N Swastika and A Hande (2015). The domino effect: Role of
hypoxia in malignant transformation of oral submucous fibrosis. J Oral Maxillofac
Pathol. 19(2): 122-127.
Chedid M, JS Rubin, KG Csaky and SA Aaronson (1994). Regulation of keratinocyte growth
factor gene expression by Interleukin-1. J. Biol. Chem. 269:10753-7.
Cheng YS, T Rees and J Wright (2014). A review of research on salivary biomarkers for oral
cancer detection. Clin Transl Med. 3:3.
Choudhari SK, G Sridharan, A Gadbail and V Poornima (2012). Nitric oxide and oral cancer: A
review. Oral Oncol. 48(6):475-483.
Choudhari SK, M Chaudhary, AR Gadbail, A Sharma and S Tekade (2014). Oxidative and
antioxidative mechanisms in oral cancer and precancer: A review. Oral Oncol. 50(1):10-
18.
Connelly ST, M Macabeo-Ong, N Dekker, RCK Jordan and BL Schmidt (2005). Increased nitric
oxide levels and iNOS over-expression in oral squamous cell carcinoma. Oral Oncol.
41:261-267.
Crabbe T, JP O’Connell, BJ Smith and AJ Docherty (1994). Biochem. 33(48):14419-25.
D’Aiuto F, L Nibali, M Parkar, K Patel, J Suvan and N Donos (2010). Oxidative stress, systemic
inflammation, and severe periodontitis. J. Dent. Res. 89:1241-1246.
Dana R, HL Malech and R Levy (1994). The requirement for phospholipase A2 for activation of
the assembled NADPH oxidase in human neutrophils. Biochem. Journal. 297:217-223.
David M and JS Richard (1983). In: methods of enzymatic analysis, Bergmeyer, J and Grab M.
(Eds), Verlag Chemie Wenhein Deer Field, Beach Floride. 358.
LITERATURE CITED
SAIMA, 2017
59
De Vicente JC, MF Fresno, L Villalain, JA Vega and GH Vallejo (2005). Expression and clinical
significance of matrix metalloproteinase-2 and matrix metalloproteinase-9 in oral
squamous cell carcinoma. Oral Oncol. 41(3):283-293.
deFreitasCordeiro-Silva M, ZF Oliveira, JR de Podesta, SA Gouvea, SV Bon Zeidler and ID
Louro (2011). Methylation analysis of cancer-related genes in non-neoplastic cells from
patients with oral squamous cell carcinoma. Mol Biol Rep. 38(8):5435-41.
Deryugina EI and JP Quigley (2006). Matrix metalloproteinases and tumor metastasis. Cancer
and Metastasis Reviews. 25(1):9-34.
Desrochers PE, JJ Jeffrey and SJ Weiss (1991). Interstitial collagenase (matrix
metalloproteinase-1) expresses serpinase activity. J. Clin. Invest. 87(6):2258-65.
Dormandy TI (1983). An approach to free radicals. Lancet.1:1010-1014.
Egeblad M and Z Werb (2002). New functions for the matrix metalloproteinases in cancer
progression. Nature Reviews Cancer. 2(3):161-174.
Endo K, Y Maehara, H Baba, M Yamamoto, S Tomisaki, A Watanabe, Y Kakeji and K
Sugimachi (1997). Eelevated levels of serum and plasma metalloproteinases in patients
with gastric cancer. Anticancer Res. 17:2253-2258.
Esmaeeli H, Y Gadimi, A Pournasrollah, R Sadeg, M Bayat, G Shirani, A Karimi, HM Hashemi,
HH Todashki, A Garajeiee and SS Kahnamouii (2015). TLR2, TLR4, TLR7 and TLR8
Expressions in Squamous cell Carcinoma of the Tongue. Adv. Environ. Biol. 9(2):520-
524.
Fang J, T Seki and H Maeda (2009). Therapeutic strategies by modulating oxygen stress in
cancer and inflammation. Adv Drug Deliv Rev. 61:290-302.
Feldman C and R Anderson (2013). Cigarette smoking and mechanisms of susceptibility to
infections of the respiratory tract and other organ systems. J Infect. 67:169-184.
Feller L and J Lemmer (2012). Oral squamous cell carcinoma: Epidemiology, clinical
presentation and treatment. J Cancer Other. 3:263-8.
Fiaschi AI, A Cozzolino, G Ruggiero and G Giorgi (2005). Glutathione, ascorbic acid and
antioxidant enzymes in the tumor tissue and blood of patients with oral squamous cell
carcinoma. Eur Rev Med Pharmacol. Sci. 9(6):361-7.
LITERATURE CITED
SAIMA, 2017
60
Figuero E, M Soory, R Cerero and A Bascones (2006). Oxidant/antioxidant interactions of
nicotine, Coenzyme Q10, Pycnogenol and phytoestrogens in oral periosteal fibroblasts
and MG63 osteoblasts. Steroids. 71(13-14):1062-1072.
Fonseca L, R Marciani and D Turvey (2008). Oral and maxillofacial surgery, 2nd ed.St. Louis
(MO), Saunders, Elsevier. 604-605.
Fosang AJ, K Last, V Knauper, G Murphy and PJ Neame (1996). Degradation of cartilage
aggrecan by collagenase-3 (MMP-13). FEBS Lett. 380(1-2):17-20.
Fosang AJ, K Last, V Knauper, PJ Neame, G Murphy, TE Hardingham, H Tschesche and JA
Hamilton (1993). Fibroblast and neutrophil collagenases cleave at two sites in the
cartilage aggrecan interglobular domain. Biochem. J. 295(Pt.1):273-6.
Fowlkes JL, JJ Enghild, K Suzuki and H Nagase (1994). Matrix metalloproteinases degrade
insulin-like growth factor-binding protein-3 in dermal fibroblast cultures. J. Biol. Chem.
269(41):25742-25746.
Fridman R, M Toth, D Pena and S Mobashery (1995). Activation of progelatinase B (MMP-9)
by gelatinase A (MMP-2). Cancer Research. 55(12):2548-2555.
Fullar A, I Kovalszky, M Bitsche, A Romani, VH Schartinger, GM Sprinzi, H Riechelmann and
J Dudas (2012). Tumor cell and carcinoma-associated fibroblast interaction regulates
matrix metalloproteinases and their inhibitors in oral squamous cell carcinoma. Exp Cell
Res. 318(13):1517-1527.
Ganesan A and NG Kumar (2014). Assessment of lipid peroxides in multiple biofluids of
leukoplakia and oral squamous cell carcinoma patients- A clinicobiochemical study.
Journal of Clinical and Diagnostic Research. 8(8):ZC55-ZC58.
Garavello W, R Foschi, R Talamini, C La Vecchia, M Rossi, L Dal Mason, A Tavani, F Levi, L
Barzan, V Ramazzotti, S Franceschi and E Negri (2008). Family history and the risk of
oral and pharyngeal cancer. Int J Cancer. 122(8):1827-1831.
Gearing AJH, P Beckett, M Christodoulou, M Churchill, J Clements, AH Davidson, AH
Drummond, WA Galloway, R Gilbert, JL Gordon et al. (1994). Nature. 370(6490):555-
7.
Geetha A, S Karthiga, G Surendran and G Jayalakshmi (2001). Biochemical studies on the level
of lipid hydroperoxide and antioxidants in different types of obstructive jaundice. J Lab
Med. 2:20-27.
LITERATURE CITED
SAIMA, 2017
61
Giannelli G et al. (1997). Science. 277:228.
Gokul S, VS Patil, R Jailkhani, K Hallikeri and KK Kattappagari (2010). Oxidant- antioxidant
status in blood and tumor tissue of oral squamous cell carcinoma patients. Oral diseases.
16:29-33.
Goldin A, JA Beckman, AM Schmidt and MA Creager (2006). Advanced glycation end products:
sparking the development of diabetic vascular injury. Circulation. 114(6):597-605.
Gonzales R, C Auclair, E Voisin, H Gautero, D Dhermy and P Boivin (1984). Superoxide
dismutase, catalase, and glutathione peroxidase in red blood cells from patients with
malignant diseases. Cancer Res. 44(9):4137-4139.
Goossens V, J Grooten, K De Vos and W Fibers (1995). Direct evidence for tumor necrosis
factor-induced mitochondrial reactive oxygen intermediates and their involvment in
cytotoxicity. Proc Natl Acad Sci USA. 92:8115-8119.
Green HN and E Mellanby (1928). Vitamin A as an anti-infective agent. Br Med J. 2(3537):691-
696.
Gu Z, M Kaul and B Yan (2002). S-nitrosylation of matrix metalloproteinases: signaling
pathway to neuronal cell death. Science. 297(5584):1186-1190.
Gupta A, MLB Bhatt and MK Misra (2009). Lipid peroxidation and antioxidant status in head
and neck squamous cell carcinoma patients. Oxid Med Cell Longev. 2(2):68-72.
Gurudath S, KS Ganapathy, D Sujatha, A Pai, S Ballal and ML Asha (2012). Estimation of
superoxide dismutase and glutathione peroxidase in oral submucous fibrosis, oral
leukoplakia and oral cancer: A comparative study. Asian Pacific J Cancer Prev.
13(9):4409-4412.
Guruprasad R, PP Nair, M Singh, M Singh, MP Singh and A Jain (2014). Serum vitamin C and
iron levels in oral submucous fibrosis. Indian Journal of Dentistry. 5(2):81-85.
Gutierrez-Venegas G, P Kawasaki-Cardenas, SR Arroyo-Cruz and S Maldonado-Frias (2006).
Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. Eur J
Pharmacol. 541(1-2):95-105.
Guttman D, Y Stern, T Shpitzer, D Ulanovski, T Druzd and R Feinmesser (2004). Expression of
MMP-9, TIMP-1, CD-34 and factor-8 as prognostic markers for squamous cell
carcinoma of the tongue. Oral Oncology. 40(8):798-803.
LITERATURE CITED
SAIMA, 2017
62
Hadler-Olsen E, B Fadnes, I Sylte, L Uhlin-Hansen and JO Weinberg (2011). Regulation of
matrix metalloproteinase activity in health and disease. FEBS Journal. 278(1):28-45.
Halliwell B (1996). Mechanisms involved in the generation of free radicals. Pathol Biol (Paris).
44:6-13.
Han YP, YD Nein and WL Garner (2002). Tumour necrosis factor-α-induced proteolytic
activation of pro-matrix metalloproteinase-9 by human skin is controlled by down
regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated
chymotrypsin-like proteinase. Journal of Biological Chemistry. 277(30):27319-27327.
Hegde ND, MD Hegde, SS Shetty and S Kumari (2013). Evaluation of salivary total
antioxidants, superoxide dismutase activity and glutathione levels in oral cancer patients.
The journal of Oral and Maxillofacial surgery. Photon. 116:150-155.
Heo DS, C Snyderman and SM Gollin (1989). Biology, cytogenetics and sensitivity to
immunological effector cells of new head and neck squamous cell carcinoma lines.
Cancer Res. 49:5167-75.
Ho SC and CT Kuo (2014). Hesperidin, nobiletin, and tangeritin are collectively responsible for
the anti-neuroinflammatory capacity of tangerine peel (Citrus reticulatae pericarpium).
Food and Chemical toxicology. 71:176-182.
Hong S, S Hong, J Lee and C Lim (2000). Expression of matrix metalloproteinase-2 and -9 in
oral squamous cell carcinomas with regard to metastatic potential. Oral Oncol.
36(2):207-213.
Hooper NM et al. (1997). Biochem J. 321:265.
Hotary K, XY Li, E Allen, SL Stevens and SJ Weiss (2006). A cancer cell metalloprotease triad
regulates the basement membrane transmigration program. Genes and Development.
20(19):2673-2686.
Howard EW, EC Bullen and MJ Banda (1991). Preferential inhibition of 72- and 92-kDa
gelatinases by tissue inhibitor of metalloproteinases-2. J Biol Chem. 266(20):13070-
13075.
Hristozov D, V Gadjeva, T Vlaykova and G Dimitrov (2001). Evaluation of oxidative stress in
patients with cancer. Arch Physiol Biochem. 109:331-336.
LITERATURE CITED
SAIMA, 2017
63
Hsin CH, MK Chen, CH Tang, HP Lin, MY Chou, CW Lin and SF Yang (2014). High level of
plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics
in patients with oral squamous cell carcinoma. PLoS ONE. 9(11):e113129.
Hubner G et al. (1996). Differential regulation of pro inflammatory cytokines during wound
healing in normal and glucocorticoid-treated mice. Cytokine. 8:548-56.
Hussain SP, LJ Hofseth and CC Harris (2003). Radical causes of cancer. Nat Rev Cancer. 3:276-
285.
Ikebe T, M Shinohara, H Takeuchi, M Beppu, S Kurahara, S Nakamura and K Shirasuna (1999).
Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the
invasiveness of oral cancer. Clin Exp Metastasis. 17(4):315-323.
Imai K, A Hiramatsu, D Fukushima et al. (1997). Degradation of decorin by matrix
metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming
growth factor-beta 1 release. (1997). Biochem J. 322:809-814.
Impola U, VJ Uitto, J Hietanen, L Hakkinen, L Zhang, H Larjava, K Isaka and U Saarialho-Kere
(2004). Differential expression of matrilysin I (MMP-7), 92 kD gelatinase (MMP-9), and
metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. Journal of
Pathology. 202(1):14-22.
Ito A, A Mukaiyama, Y Itoh, H Nagase, IB Thogersen, JJ Enghild, Y Sasaguri and Y Mori
(1996). Degradation of interleukin 1beta by matrix metalloproteinases. J. Biol. Chem.
271(25):14657-60.
Jablonska E, Piotrowski L and Grabowska Z (1997). Serum levels of IL- 1β, IL-6, TNF-α, sTNF-
RI and CRP in patients with oral cavity cancer. Pathol Oncol Res. 3(2):126-9.
Jacob RA and BJ Burri (1996). Oxidative damage and defense. Am J Clin Nutrition. 63:985-90.
Jafarian AH, LV Mostaan, NM Roshan, K Khazaeni, S Parsazad and H Gilan (2015).
Relationship between the expression of matrix metalloproteinases and clinicopathologic
features in oral squamous cell carcinoma. Iranian Journal of Otorhinolaryngology.
27(3):219-223.
Jalouli J, SO Ibrahim, R Mehrotra, MM Jalouli, D Sapkota and PA Larsson (2010). Prevalence
of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from
India. Acta Otolaryngol. 130(11):1306-1311.
LITERATURE CITED
SAIMA, 2017
64
Jalouli J, SO Ibrahim, R Mehrotra, MM Jalouli, D Sapkota, PA Larsson and JM Hirsch (2010).
Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral
cancer from India. Acta Otolaryngol. 130(11):1306-1311.
Jenkin DC, IG Charles, LL Thomson, DW Moss, LS Holmes and SA Baylis (1995). Role of
nitric oxide in tumor growth. Proc Natl Acad Sci USA. 92:4392-4396.
Jin L and RV Lloyd (1997). In situ hybridization: methods and applications. Journal of Clinical
Laboratory Analysis. 11(1):2-9.
Jomova K, D Vondrakova, M Lawson and M Valko (2010). Metals, oxidative stress and
neurodegenerative disorders. Mol. Cell. Biochem. 345:91–104.
Jones KR, RD Lodge-Rigal, RL Reddick, GE Tudor and WW Shockley (1992). Prognostic
factors in the recurrence of stage I and II squamous cell cancer of the oral cavity. Arch
Otolaryngol Head Neck Surg. 118(5):483-485.
Jordan RC, M Macabco-Ong, CH Shiboski, N Dekker, D Ginzinger, DW Wong and BL Schmidt
(2004). Over expression of matrix metalloproteinase-1 and -9 mRNA is associated with
progression of oral dysplasia to cancer. Clin Cancer Res. 10(19):6460-5.
Jozsef L, T Khreiss, DEl Kebir and JG Filep (2006). Activation of TLR-9 induces IL-8 secretion
through peroxynitrite signaling in human neutrophils. J Immunol. 176:1195-1202.
Kademani D, RB Bell, S Bagheri, E Holmgren, E Dierks, B Potter and L Homer (2005).
Prognostic factors in intraoral squamous cell carcinoma: the influence of histologic
grade. J Oral Maxillofac Surg. 63(11):1599-1605.
Kakkar P, B Das and PN Viswanathan (1984). A modified spectrophotometric assay of
superoxide dismutase. Indian J Biochem Bio. 21:130-132.
Kalousova M, T Zima, V Tesar, S Dusilova-Sulkova and J Skrha (2005). Advanced glycoxidation
end products in chronic diseases-clinical chemistry and genetic background. Mutation
research. 10.
Kampa M, VI Alexaki, G Notas et al. (2004). Antiproliferative and apoptotic effects of selective
phenolic acids on T47D human breast cancer cells: potential mechanisms of action.
Breast Cancer Res. 6(2):R63-74.
Kang DH (2002). Oxidative stress, DNA damage, and breast cancer. AACN Advanced Critical
Care. 13(4):540-549.
LITERATURE CITED
SAIMA, 2017
65
Katayama A, N Bandoh, K Kishibe, M Takahara, T Ogino, S Nonaka and Y Harabuchi (2004).
Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as
predictive indicators for tumor metastases and prognosis. Clin Cancer Res. 10(2):634-
40.
Kato K, A Hara, T Kuno, N Kitaori, Z Huilan, H Mori, M Toida and T Shibata (2005). Matrix
metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestations and
localization of their activity. Journal of Cancer Research and Clinical Oncology.
131(6):340-346.
Kawai T and S Akira (2010). The role of pattern-recognition receptors in innate immunity:
update on Toll-like receptors. Nat. Immunol. 11:373-384.
Kawata R, T Shimada, S Maruyama, Y Hisa, H Takenaka and Y Murakami (2002). Enhanced
production of matrix metalloproteinase-2 in human head and neck carcinomas is
correlated with lymph node metastasis. Acta Otolaryngol. 122:101-106.
Kersse K, MJ Bertrand, M Lamkanfi and P Vandenabeele (2011). NOD-like receptors and the
innate immune system: coping with danger, damage and death. Cytokine growth Factor
Rev. 22:257-276.
Khandrika L, B Kumar, S Koul, P Maroni and HK Koul (2009). Oxidative stress in prostate
cancer. Cancer Lett. 282:125-136.
Khanna S (2008). Immunological and biochemical markers in oral carcinogenesis. The public
health perspective. Int. J. Environ. Res. Public Health. 5(5):418-422.
Khanna SS and FR Karjodkar (2006). Circulating immune complexes and trace elements
(Copper, Iron and Selenium) as markers in oral precancer and cancer: a randomized,
controlled clinical trial. Head & face medicine. 2(33):1-10.
Klein T and R Bischoff (2011). Physiology and pathophysiology of matrix metalloproteinases.
Amino acids. 41(2):271-290.
Knauper V, B Smith, C Lopez-Otin and G Murphy (1997). Activation of progelatinase B (pro
MMP-9) by active collagenase-3 (MMP-13). European Journal of Biochemistry.
248(2):369-373.
Knauper V, H Will, C Lopez-Otin, B Smith, SJ Atkinson, H Stanton, RM Hembry and G
Murphy (1996). Cellular mechanisms for human procollagenase-3 (MMP-13) activation.
LITERATURE CITED
SAIMA, 2017
66
Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate
active enzyme. J. Biol. Chem. 271(29):17124-31.
Kolanjiappan K, CR Ramchandran and S Manoharan (2003). Biochemical changes in tumor
tissues of oral cancer patients. Clin Biochem. 36(1):61-5.
Korde S, A Basak, M Chaudhary, M Goyal and A Vagga (2011). Enhanced nitrosative and
oxidative stress with decreased total antioxidant capacity in patients with oral precancer
and oral squamous cell carcinoma. Oncology. 80(5-6):382-9.
Krishna Prasad RB, A Sharma and HM Babu (2013). An insight into salivary markers in oral
cancer. Dent Res J (Isfahan). 10(3):287-95.
Krishnan R, DK Thayalan, R Padmanaban, R Ramadas, RK Annasamy and N Anandan (2014).
Association of serum and salivary tumour necrosis factor-α with histological grading in
oral cancer and its role in differentiating premalignant and malignant oral disease. Asian
Pac J Cancer Prev. 15(17):7141-7148.
Kurokawa H, M Yamashita, Y Yamashita, T Murata, K Miura and M Kajiyama (1998).
Estimation of tumour necrosis factor- alpha in the diagnosis, the prognosis and the
treatment follow-up of oral squamous cell carcinoma. Fukuoka Igaku Zasshi. 89:312-20.
Kurtul N and E Gokpinar (2012). Salivary lipid peroxidation and total sialic acid levels in
smokers and smokeless tobacco users as maras powder. Mediators Inflamm. 619293.
Lawrence E (2015). In: Vitamin supplements energy.
Lee J, V Taneja and R Vassallo (2012). Cigarette smoking and inflammation: Cellular and
molecular mechanisms. J Dent Res. 91:142-149.
Lee KM, BS Kang, HL Lee, SJ Son, SH Hwang, DS Kim, JS Park and HJ Cho (2004). Spinal
NF-κB activation induces COX-2 upregulation and contributes to inflammatory pain
hypersensitivity. Eur. J. Neurosci. 19:3375-3381.
Lee SY, HJ Kim, WJ Lee, SH Joo, SJ Jeon, JW Kim et al. (2008). Differential regulation of
matrix metalloproteinase-9 and tissue plasminogen activator activity by the cyclic-AMP
system in lipopolysaccharide-stimulated rat primary astrocytes. Neurochem Res.
33:2324-2334.
Lee SY, NH Cho, EC Choi, SJ Baek, WS Kim and DH Shin (2010). Relevance of human
papilloma virus (HPV) infection to carcinogenesis of oral tongue cancer. Int J Oral
Maxillofac Surg. 39(7):678-683.
LITERATURE CITED
SAIMA, 2017
67
Lee YS (2005). Role of NADPH oxidase-mediated generation of reactive oxygen species in the
mechanism of apoptosis induced by phenolic acids in HepG2 human hepatoma cells.
Arch Pharm Res. 28(10):1183-1189.
LePage RN, AJ Fosang, SJ Fuller, G Murphy, G Evin, K Beyreuther and DH Small
(1995).Gelatinase A possesses a beta-secretase-like activity in cleaving the amyloid
protein precursor of Alzheimer’s disease. FEBS Lett. 377(2):267-70.
Lesca P (1983). Protective effects of ellagic acid and other plant phenols on benzo[a]pyrene-
induced neoplasia in mice. Carcinogenesis. 4(12):1651-1653.
Letchoumy PV, KV Mohan, JJ Stegeman et al. (2008). In vitro antioxidative potential of
lactoferrin and black tea polyphenols and protective effects in vivo on carcinogen
activation, DNA damage, proliferation, invasion, and angiogenesis during experimental
oral carcinogenesis. Oncol Res. 17(5):193-203.
Levi E, R Fridman, HQ Miao, YS Ma, A Yayon and I Vlodavsky (1996). Matrix
metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor
receptor 1. Proc. Natl. Acad. Sci. USA. 939(14):7069-74.
Li X, Q Xu, Y Wu, J Li, D Tang, L Han and Q Fan (2014). A CCL2/ROS autoregulation loop is
critical for cancer-associated fibroblasts-enhanced tumor growth of oral squamous cell
carcinoma. Carcinogenesis. 35(6):1362–1370.
Liboiron BD and LD Mayer (2014). Nanoscale particulate systems for multidrug delivery:
towards improved combination chemotherapy. Ther Deliv. 5(2):149-171.
Lippman SM and WK Hong (2001). Molecular markers of the risk of oral cancer. N Engl J Med.
344(17):1323-1326.
Liu CJ, KW Chang, SC Lin and HW Cheng (2009). Presurgical serum levels of matrix
metalloproteinase-9 and vascular endothelical growth factor in oral squamous cell
carcinoma. Oral Oncol. 45(10):920-5.
Liu SX, FF Hou, ZJ Guo, R Nagai, WR Zhang, ZQ Liu, ZM Zhou, M Zhou, D Xie, GB Wang
and X Zhang (2006). Advanced oxidation protein products accelerate atherosclerosis
through promoting oxidative stress and inflammation. Arterioscler Thromb Vasc Biol.
26:1156-1162.
LITERATURE CITED
SAIMA, 2017
68
Liu YE, M Wang, J Greene, J Su, S Ullrich, H Li, S Sheng, P Alexander, QA Sang and YE Shi
(1997). Preparation and characterization of recombinant tissue inhibitor of
metalloproteinase 4 (TIMP-4). J Biol Chem. 272(33):20479-20483.
Lu H, W Ouyang and C Huang (2006). Inflammation, a key event in cancer development.
Molecular Cancer Research. 4(4):221-233.
Lugrin J, N Rosenblatt-Velin, R Parapanov and L Liaudet (2014). The role of oxidative stress
during inflammatory processes. Biol. Chem. 395(2):203-230.
Malik UU, IA Siddiqui, Z Hashim and S Zarina (2014). Measurement of serum paraoxonase
activity and MDA concentrations in patients suffering with oral squamous cell
carcinoma. 430:38-42.
Manju V, JK Sailaja and N Nalini (2002). Circulating lipid peroxidation and antioxidant status in
cervical cancer patients: a case-control study. Clin Biochem. 35:621-625.
Manoharan S, K Kolanjiappan, K Suresh and K Panjamurthy (2005). Lipid peroxidation and
antioxidants status in patients with oral squamous cell carcinoma. Indian J Med Res.
122:529-534.
Manoharan S, S Shreeram and S Nagini (1996). Life style can induce lipid peroxidation and
compromise of antioxidant defence mechanisms in the erythrocytes of oral cancer
patients. Med Sci Res. 24:397-400.
Margioris A (2009). Fatty acids and post prandial inflammation. Current Opinion in Clinical
Nutrition and Metabolic Care. 12:129-137.
Marichalar-Mendia X, A Acha-Sagredo, MJ Rodriguez-Tojo, N Rey-Barja, M Hernando-
Rodriguez, JI Aguirregaviria and JM Aguirre-Urizar (2011). Alcohol-dehydrogenase
(ADH1B) Arg48His polymorphism in Basque country patients with oral and laryngeal
cancer: preliminary study. Anticancer Res. 31(2):677-80.
Markopoulos AK (2012). Current aspects on oral squamous cell carcinoma. Open Dent J. 6:126-
30.
Markopoulos AK, EZ Michailidou and G Tzimagiorgis (2010). Salivary markers for oral cancer
detection. Open Dent J. 4:172-8.
Martinon F, A Mayor and J Tschopp (2009). The inflammosomes: guardians of the body. Annu.
Rev. Immunol. 27:229-265.
LITERATURE CITED
SAIMA, 2017
69
Marx RE and D Stern (2003). Oral and maxillofacial pathology: a rationale for diagnosis and
treatment. Chicago (IL), Quintessence publishing Co. Inc. 284-290.
Massano J, FS Regateiro, G Januario and A Ferreira (2006). Oral squamous cell carcinoma:
review of prognostic and predictive factors. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod. 102(1):67-76.
Mast AE, JJ Enghild, H Nagase, K Suzuki, SV Pizzo and G Salvesen (1991). Kinetics and
physiologic relevance of the inactivation of alpha 1-proteinase inhibitor, alpha 1-
antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue
collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromeolysin). J. Biol.
Chem. 266(24):15810-6.
Mates JM, C Perez-Gomez and CI Nunez (1999). Antioxidant enzymes and human disease. Clin
Biochem. 32:595-603.
Mazzieri R, L Masiero, L Zanetta, S Monea, M Onisto, S Garbisa and P Mignatti (1997). Control
of type IV collagenase activity by the urokinase-plasmin system: a regulatory
mechanism with cell bound reactants. EMBO J. 16(9):2319-2332.
Mc Dowell JD (2006). An overview of epidemiology and common risk factors for oral squamous
cell carcinoma. Otolaryngol Clin North Am. 39:277-294.
Mehrotra R and DK Gupta (2011). Exciting new advances in oral cancer diagnosis: avenues to
early detection. Head and Neck Oncol. 3:33.
Mehrotra R and S Yadav (2006). Oral squamous cell carcinoma: etiology, pathogenesis and
prognostic value of genomic alterations. Indian J Cancer. 43:60-66.
Meister A (1988). Glutathione metabolism and its selective modification. J Biochem. 263:17205-
17208.
Metgud R and S Bajaj (2014). Evaluation of salivary and serum lipid peroxidation and
glutathione in oral leukoplakia and oral squamous cell carcinoma. J Oral Sci. 56(2):135-
142.
Mishev G, E Deliverska, R Hlushchuk, N Velinov, D Aebersold, F Weinstein and V Djonov
(2014). Prognostic value of matrix metalloproteinases in oral squamous cell carcinoma.
Biotechnology & Biotechnological equipment. 28(6):1138-1149.
LITERATURE CITED
SAIMA, 2017
70
Mitchell TI, JJ Jeffrey, RD Palmiter and CE Brinckerhoff (1993). The acute phase reactant
serum amyloid A (SAA3) is a novel substrate for degradation by the metalloproteinases
collagenase and stromelysin. Biochim. Biophys. Acta. 1156(3):245-54.
Miyazaki K, M Hasegawa, K Funahashi and M Umeda (1993). A metalloproteinase inhibitor
domain in Alzheimer amyloid protein precursor. Nature. 362(6423):839-41.
Montoro JR, HA Ricz, Ld Souza, D Livingstone, DH Melo, RC Tiveron and RC Mamede
(2008). Prognostic factors in squamous cell carcinoma of the oral cavity. Braz J
Otorhinolaryngol. 74(6):861-866.
Mori H, K Kawabata, N Yoshimi et al. (1999). Chemopreventive effects of ferulic acid on oral
and rice germ on large bowel carcinogenesis. Anticancer Res. 19(5A):3775-3778.
Moron MS, JW Depierre and B Mannervik (1979). Levels of glutathione, glutathione reductase
reductase and glutathione-S-transferase activities in rat lung and liver. Biochem Biophys
Acta. 582:67-72.
Mukherjee S, JG Ray and K Chaudhuri (2010). Microscopic analysis of histological and
immunohistochemical sections to differentiate normal, precancer and cancerous oral
squamous epithelial tissues. Microscopy: Science, Technology, Applications and
Education. (Eds). Mendez-Vilas A, J Diaz. 993-1000.
Murphy G, MI Cockett, RV Ward and AJ Docherty (1991). Matrix metalloproteinase
degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of
the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and-2 and punctuated
metalloproteinase (PUMP). Biochemical Journal. 277(1), 277-279.
Murray GI (2001). Matrix metalloproteinases: a multifunctional group of molecules. J Pathol.
195:135-137.
Nagao Y and M Data (2009). High incidence of multiple primary carcinomas in HCV-infected
patients with oral squamous cell carcinoma. Med Sci Monit. 15:CR453-9.
Nagase H, R Visse and G Murphy (2006). Structure and function of matrix metalloproteinases
and TIMPs. Cardiovascular Research. 69(3):562-573.
Nagini S, S Manoharan and CR Ramchandran (1998). Lipid peroxidation and antioxidants in
oral squamous cell carcinoma. Clin Chim Acta. 273:95-98.
Naik E and VM Dixit (2011). Mitochondrial reactive oxygen species drive pro-inflammatory
cytokine production. J. Exp. Med. 208:417-420.
LITERATURE CITED
SAIMA, 2017
71
Nakamura H, Y Fujii, E Ohuchi, E Yamamoto and Y Okada (1998). Activation of the precursor
of human stromeolysin 2 and its interactions with other matrix metalloproteinases.
European Journal of Biochemistry. 253(1):67-75.
Nakano Y, W Kobayashi, S Sugai, H Kimura and S Yagihashi (1999). Expression of tmour
necrosis factor-alpha and interleukin-6 in oral squamous cell carcinoma. Jpn J Cancer
Res. 90:858-66.
Nathan C and A Cunningham-Bussel (2013). Beyond oxidative stress: an immunologist’s guide
to reactive oxygen species. Nat. Rev. Immunol. 13:349-361.
Neville BW and TA Day (2002). Oral cancer and precancerous lesions. A cancer journal for
clinicians. 52(4):195-215.
Nguyen Q, G Murphy, CE Hughes, JS Mort and PJ Roughley (1993). Matrix metalloproteinases
cleave at two distinct sites on human cartilage link protein. Biochem J. 295(Pt 2):595-8.
Nishida M, SG Grossi, RG Dunford, A How, M Trezisan and RJ Genco (2000). Dietary vitamin
C and the risk for periodontal disease. J Periodontol. 71:1215.
Nishino T, K Okamoto, BT Eger and EF Pai (2008). Mammalian xanthine oxidoreductase –
mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J.
275:3278–3289.
Nuovo GJ (2011). In situ detection of human papillomavirus DNA after PCR-amplification.
Methods Mol Biol. 688:35-46.
Ochieng J (1994). Biochem. 33:14109.
O'Connell JP, F Willenbrock, AJP Docherty, D Eaton and G Murphy (1994). Analysis of the role
of the COOH- terminal domain in the activation, proteolytic activity, and tissue inhibitor
of metalloproteinase interactions of gelatinase B. Journal of Biological Chemistry.
269(21):14967-14973.
Ogata Y, JJ Enghild and H Nagase (1992). Matrix metalloproteinase 3 (stromelysin) activates the
precursor for the human matrix metalloproteinase 9. Journal of Biological Chemistry.
267(6):3581-3584.
Ogden GR (2005). Alcohol and oral cancer. Alcohol. 35:169-73.
Ohkawa H, N Ohishi and K Yagi (1979). Assay for lipid peroxides in animal tissues by
thiobarbituric acid reaction. Anal Biochem. 95:351-8.
LITERATURE CITED
SAIMA, 2017
72
Ohnishi S, N Ma, R Thanan, S Pinlaor, O Hammam, M Murat and D Kawanishi (2013). DNA
damage in inflammation-related carcinogenesis and cancer stem cells. Oxid. Med. Cell.
Longev. 1-9.
Oliveira LR, A Castilho-Fernandes, JP Oliveira-Costa, FA Soares, S Zucoloto and AR Silva
(2014). CD44+/CD133+ imunophenotype and matrix metalloproteinase-9: Influence on
prognosis in early-stage oral squamous cell carcinoma. Head Neck. 36(12):1718-26.
O'Neill LA, D Golenbock and AG Bowie (2013). The history of Toll-like receptors redefining
innate immunity. Nat Rev Immunology. 13:453-460.
Osaka T, T Kimura, Y Tatemoto, T Yamamoto and K Yoneda (2000). Risk factors of metastasis
in oral squamous cell carcinomas. Oncology. 58:137-143.
Panchenko MV, WG Stetler-Stevenson, OV Trubetskoy, SN Gacheru and HM Kagan (1996).
Metalloproteinase activity secreted by fibrogenic cells in the processing of prolysyl
oxidase. Potential role of procollagen C-proteinase. J. Biol. Chem. 271(12):7113-9.
Pandya NM, NS Dhalla and DD Santani (2006). Angiogenesis- a new target for future therapy.
Vascular Pharmacology. 44(5):265-274.
Parkin DM, F Bray, J Ferlay and P Pisani (2005). Global cancer statistics, 2002. CA Cancer J
Clin. 55(2):74-108.
Patait MR, RN Mody and S Khanzode (2011). Estimation of serum lipid peroxides before and
after radiotherapy in oral squamous cell carcinoma patients. Int J Oral & Maxillofacial
Pathology. 2(3):13-18.
Patel BP, SV Shah, SN Shukla, PM Shah and PS Patel (2007). Clinical significance of MMP-2
and MMP-9 in patients with oral cancer. Head and Neck. 29(6):564-572.
Patel BP, UM Rawal, TK Dave, RM Rawal, SN Shukla, PM Shah and PS Patel (2007). Lipid
peroxidation, total antioxidant status, and total thiol levels predict overall survival in
patients with oral squamous cell carcinoma. Integr Cancer Ther. 6(4):365-372.
Patel JB, FD Shah, SN Shukla, PM Shah and PS Patel (2009). Role of nitric oxide and
antioxidant enzymes in the pathogenesis of oral cancer. Journal of cancer research and
therapeutics. 5(4):247-253.
Patel SC, WR Carpenter, S Tyree, ME Couch, M Weissler, T Hackman, DN Hayes, C Shores
and BS Chera (2011). Increasing incidence of oral tongue squamous cell carcinoma in
young white women, age 18 to 44 years. J Clin Oncol. 29(11):1488-94.
LITERATURE CITED
SAIMA, 2017
73
Patterson BC and QXA Sang (1997). Angiostatin-converting enzyme activities of human
matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem.
272(46):28823-5.
Patton LL, JB Epstein and AR Kerr (2008). Adjunctive techniques for oral cancer examination
and lesion diagnosis: a systematic review of literature. J Am Dent Assoc. 139:896-905.
Pejic S, A Todorovic, V Stojiljkovic, J Kasapovic and SB Pajovic (2009). Antioxidant enzymes
and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and
adenocarcinoma. Reproductibe Biology and Endocrinology. 7:49.
Peppin GJ and SJ Weiss (1986). Activation of endogenous metalloproteinase, gelatinase, by
triggered human neutrophils. Process. Nat. Am Sci USA. 83(12):4322-4326.
Perides G, RA Asher, MW Lark, WS Lane, RA Robinson and A Bignami (1995). Glial
hyaluronate-binding protein: a product of metalloproteinase digestion of versican?
Biochem J. 312(Pt 2):377-84.
Petti S (2009). Lifestyle risk factors for oral cancer. Oral Oncol. 45(4):340-350.
Pham-Huy LA, H He and C Pham-Huy (2008). Free radicals, antioxidants in disease and health.
International Journal of Biomedical Science. 4(2):89-96.
Pintos J, MJ Black, N Sadeghi, P Ghadirian, AG Zeitouni and RP Viscidi (2008). Human
papillomavirus infection and oral cancer: a case-control study in Montreal, Canada. Oral
Oncol. 44(3):242-250.
Pirila E, P Maisi, T Salo, E Koivunen and T Sorsa (2001). In vivo localization of gelatinases
(MMP-2 and -9) by in situ zymography with a selective gelatinase inhibitor.
Biochemical and Biophysical Research Communications. 287(3):766-774.
Popov D (2012). Endoplasmic reticulum stress and the onsite function of resident PTP1B.
Biochem. Biophys. Res. Commun. 422:535–538.
Poyton RO, KA Ball and PR Castillo (2009). Mitochondrial generation of free radicals and
hypoxic signaling. Trends Endocrinol Metab. 20:332-340.
Prasad G and M McCullough (2013). Chemokines and cytokines as salivary biomarkers for the
early diagnosis of oral cancer. Into J Dent. 2013:813756.
Prazma J, P Pctrusz, W Mims, SS Ball and MC Weissler (1995). Immunohistochemical
characterization of nitric oxide synthase in squamous cell carcinoma of the head and
neck. Otolaryngol Head Neck Surg. 113:541-549.
LITERATURE CITED
SAIMA, 2017
74
Pritsos CA (2000). Cellular distribution, metabolism and regulation of the xanthine
oxidoreductase enzyme system. Chem. Biol. Interact. 129:195–208.
Raghuwanshi U, SC Choudhari and R Patil (2012). Serum α-tocopherol levels indicating status
of oral carcinoma patients. Int J Health Sci Res. 2(9):60-64.
Ramaswamy PG, L Krishnamoorthy, VR Rao and MK Bhargava (1990). Vitamin and provitamin
A levels in epithelial cancers: a preliminary study. Nutr Cancer. 14(3-4):273-6.
Ramya R, S Prakash and S Sudha (2011). Assessment of serum malondialdehyde in oral
squamous cell carcinoma patients and its association with tobacco habits. JPBMS.
10(16).
Rasheed MH, SS Beevi and A Geetha (2007). Enhanced lipid peroxidation and nitric oxide
products with deranged antioxidant status in patients with head and neck squamous cell
carcinoma. Oral Oncol. 43(4):333-338.
Rasool M, SR Khan, A Malik, KM Khan, S Zahid, A Manan, MH Qazi and MI Naseer (2014).
Comparative studies of salivary and blood sialic acid, lipid peroxidation and
antioxidative status in oral squamous cell carcinoma. Pak J Med Sci. 30(3):466-471.
Raverdeau M and KH Mills (2014). Modulation of T cell and innate immune responses by
retinoic acid. J Immunol. 192(7):2953-2958.
Ravi DK, M Kumar, G Singh, SB Rai, T Chincholkar, AK Saxena and M Pandey (2014). Matrix
metallopeptidase 9 (MMP -9) expressions in oral cancer and adjacent normal tissue.
World Journal of Surgical Medical and Radiation Oncology. 4.
Ray G and SA Hussein (2002). Oxidants, anti-oxidants and carcinogenesis. Ind J Exp Biology.
40:1213-32.
Ray G, S Batra, NK Shukla, S Deo, V Raina,S Ashok and SK Husain (2000). Lipid peroxidation,
free radical production and antioxidant status in breast cancer. Breast Cancer Res Treat.
59:163-170.
Rehman K (2007). Studies on free radicals, antioxidants and cofactors. Clin. Interv. Aging. 2(2):
219-236.
Reuter S, SC Gupta, MM Chaturvedi and BB Aggarwal (2010). Oxidative stress, inflammation,
and Cancer: How are they linked? Free Radic Biol Med. 49(11):1603-1616.
LITERATURE CITED
SAIMA, 2017
75
Reuven EM, A Fink and Y Hai (2014). Regulation of innate immune responses by trans
membrane interactions: lessons from the TLR family. Biochim Biophys Acta.
1838(6):1586-93.
Rhodus NL, B Cheng, S Myers, L Miller, V Ho and F Ondrey (2005). The feasibility of
monitoring NF-kappaB associated cytokines: TNF-alpha, IL-1alpha, IL-6, and IL-8 in
whole saliva for the malignant transformation of oral lichen planus. Mol Carcinog.
44:77-82.
Roher AE, TC Kasunic, AS Woods, RJ Cotter, MJ Ball and R Fridman (1994). Proteolysis of A
beta peptide from Alzheimer disease brain by gelatinase A. Biochem. Biophys. Res.
Commun. 205(3):1755-61.
Rosenberg HR (1992). Chemistry and physiology of the vitamins, Interscience publisher, New
York. 452-453.
Rossi B, G Schinzari, G Maccauro, L Scaramuzzo, D Signorelli, MA Rosa, C Fabbriciani and B
Carlo (2010). Neoadjuvant multidrug chemotherapy including high-dose methotrexate
modifies VEGF expression in osteosarcoma: an immunohistochemical analysis. BMC
Musculoskelet Disord. 11:34.
Roth MJ, KL Strickland and GQ Wang (1998). High levels of carcinogenic polycyclic aromatic
hydrocarbons present within food from Linxian, China may contribute to that region’s
high incidence of esophageal cancer. Eur J Cancer. 34:757-758.
Roukolainen H, P Paakko and T Turpeenniemi-Hujanen (2005). Serum matrix
metalloproteinase-9 in head and neck squamous cell carcinoma is a prognostic marker.
Int J cancer. 116:422-427.
Royack GA, MP Nguyen, DC Tong et al. (2000). Response of human oral epithelial cells to
oxidative damage and the effect of vitamin E. Oral Oncol. 36(1):37-41.
Ruan M, Z Zhang, S Li, M Yan, S Liu, W Yang, L Wang and C Zhang (2014). Activation of
toll-like receptor-9 promotes cellular migration via up-regulating MMP-2 expression in
oral squamous cell carcinoma. PLoS ONE. 9(3):e92748.
Rundhaug JE (2003). Matrix metalloproteinases, Angiogenesis, and Cancer: Commentary re:
Lockhart AC et al. Reduction of wound angiogenesis in patients treated with BMS-
275291, a broad spectrum matrix metalloproteinase inhibitor. Clin. Cancer Res. 9:551-
554.
LITERATURE CITED
SAIMA, 2017
76
Rusthoven KE, D Raben, JI Song, M Kane, TA Altoos and C Chen (2010). Survival and patterns
of relapse in patients with oral tongue cancer. J Oral Maxillofac Surg. 68(3):584-589.
Sabitha KE and CS Shayamaladevi (1999). Oxidant and antioxidant activity changes in patients
with oral cancer and treated with radiotherapy. Oral Oncology. 35(3):273-277.
Saheb Jamee M, M Eslami, FA Moghadam and A Sarafnejad (2008). Salivary concentration of
TNF-alpha, IL-1alpha, IL6, and IL8 in oral squamous cell carcinoma. Med Oral Patol
Oral Cir Bucal. 13:E292-5.
Salzman R, L Pacal, J Tomandl, K Kankova, E Tothova, R Gal, R Kostrica and P Salzman
(2009). Elevated malondialdehyde correlates with the extent of primary tumor and
predicts poor prognosis of oropharyngeal cancer. International Institute of Anticancer
Research.
San Miguel SM, LA Opperman and KK Svoboda (2010). Antioxidants increased in vitro wound
healing of nicotine-treated oral fibroblasts. FASEB J. (meeting abstract supplement
181.2)
San Miguel SM, LA Opperman, EP Allen, J Zielinski and KK Svoboda (2010). Antioxidants
counteract nicotine and promote migration via RacGTP in oral fibroblast cells, J
Periodontology. 81(11):1675-90.
Sasaki T, W Gohring, K Mann, P Maurer, E Hohenester, V Knauper, G Murphy and R Timpl
(1997). Limited cleavage of extracellular matrix protein BM-40 by matrix
metalloproteinases increases its affinity for collagens. J. Biol. Chem. 272(14):9237-43.
Schetter AJ, NHH Heegard and CC Harris (2010). Inflammation and cancer: interweaving
microRNA, free radical, cytokine and p53 pathways. Carcinogenesis. 31(1):37-49.
Scott SE, EA Grunfeld, J Main and M McGurk (2006). Patient delay in oral cancer: a qualitative
study of patient's experiences. Psycho oncology. 15:474-85.
Scully C and J Bagan (2009). Oral squamous cell carcinoma overview. Oral Oncol. 45(4):301-
308.
Scully C and JV Bagan (2007). Recent advances in oral oncology. Oral Oncol. 43:107-115.
Seaman DR (2006). Nutrient considerations for pain and Inflammation. In: Liebenson CL,
Editor. Rehabilitation of the spine: A practitioner’s manual. Baltimore: Willaims &
Wilkens. 728-40.
LITERATURE CITED
SAIMA, 2017
77
Seaman DR (2007). Nutritional considerations in the treatment of soft tissue injuries. In:
Hammer WI, Editor. Functional soft tissue examination and treatment by manual
methods, 3rd ed. Boston: Jones and Bartlett.
Segal BH, MJ Grimm, AN Khan, W Han and TS Blackwell (2012). Regulation of innate
immunity by NADPH oxidase. Free Radic. Biol. Med. 53:72–80.
Senior RM, GL Griffin, CJ Fliszar, SD Shapiro, GI Goldberg and HG Welgus (1991). Human
92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266(12):7870-5.
Shah JP and Z Gil (2009). Current concepts in management of oral cancer-surgery. Oral Oncol.
45(4):394-401.
Sharma M, M Rajappa, G Kumar and A Dharma (2009). Oxidant-antioxidant status in Indian
patients with carcinoma of posterior one-third of tongue. Cancer Biomark. 5(6):253-60.
Sharma P, S Saxena and P Aggarwal (2010). Trends in the epidemiology of oral squamous cell
carcinoma in Western UP: an institutional study. Ind J Dent Red. 21:316-9.
Shetty SR, S Babu, S Kumari, P Shetty, R Vijay and A Karikal (2013). Serum glutathione levels
in oral leukoplakia and oral squamous cell carcinoma- A clinicopathological study.
American Journal of Cancer Prevention. 1(1):1-3.
Shetty SR, S Babu, S Kumari, P Shetty, S Hegde and R Castelino (2014). Status of salivary lipid
peroxidation in oral cancer and precancer. Indian J Med Paediatr Oncol. 35:156-8.
Shetty SR, SG Babu, S Kumari, A Karikal, P Shetty and S Hegde (2013). Salivary superoxide
dismutase levels in oral leukoplakia and oral squamous cell carcinoma: a
clinicopathological study. Oxid Antioxid Med Sci. 2(1):69-71.
Shi Y and J Massague (2003). Mechanisms of TGF-β signaling from cell membrane to the
nucleus. Cell. 113:685-700.
Shiboski CH, BL Schmidt and RC Jordan (2005). Tongue and tonsil carcinoma: increasing
trends in the US population ages 20-44 years. Cancer. 103(9):1843-49.
Shilpasree AS, K Kumar, M Itagappa and G Ramesh (2013). Study of oxidative stress and
antioxidant status in oral cancer patients. International Journal of oral and Maxillofacial
pathology. 4(2):2-6.
Shivashankara AR and MK Prabhu (2011). Salivary total protein, sialic acid, lipid peroxidation
and glutathione in oral squamous cell carcinoma. Biomedical research. 22(3):355-359.
LITERATURE CITED
SAIMA, 2017
78
Siddiqui IA, MU Farooq, RA Siddiqui and SMT Rafi (2006). Role of toluidine blue in early
detection of oral cancer. Pak J Med Sci. 22:184-7.
Singh AP, N Kumar, MS Raju, NN Singh and SG Nagendrareddy (2014). Estimation of serum
β2-microglobin in potentially malignant disorders and Squamous cell carcinoma of the
oral cavity: A clinicopathological study. Dent. Res. J. (Isafahan). 11(1):109-13.
Singh H, P Shetty, SV Sreelatha and M Patidar (2014). Analysis of salivary antioxidant levels in
different clinical staging and histological grading of oral squamous cell carcinoma:
Noninvasive technique in Dentistry. Journal of clinical and diagnostic research.
8(8):ZC08-ZC11.
Singh RD, N Haridas, JB Patel, FD Shah, SN Shukla, PM Shah and PS Patel (2010). Matrix
metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral
cancer. Indian J Clin Biochem. 25(3):250-259.
Sires UI, B Dublet, E Aubert-Foucher, M van der Rest and HG Welgus (1995). Degradation of
the COL1 domain of type XIV collagen by 92-kDa gelatinase. J. Biol. Chem.
270(3):1062-7.
Sires UI, G Murphy, VM Baragi, CJ Fliszar, HG Welgus and RM Senior (1994). Matrilysin is
much more efficient than other matrix metalloproteinases in the proteolytic inactivation
of alpha 1-antitrypsin. Biochem. Biophys. Res. Commun. 240(2):613-20.
Sires UI, GL Griffin, TJ Broekelmann, RP Mecham, G Murphy, AE Chung, HG Welgus and RM
Senior (1993). Degradation of entactin by matrix metalloproteinases. Susceptibility to
matrilysin and identification of cleavage sites. J. Biol. Chem. 268(3):2069-74.
Snoek-van Beurden PAM and JW Von Den Hoff (2005). Zymographic techniques for the
analysis of matrix metalloproteinases and their inhibitors. Bio Techniques. 38(1):73-83.
Soni S, M Mathur, NK Shukla, SV Deo and R Ralhan (2003). Stromelysin-3 expression is an
early event in human oral tumorigenesis. Int J Cancer. 107:309-316.
Sorsa T, T Salo, E Koivunen, J Tyynela, YT Konttinen, U Bergmann, A Tuuttila, E Niemi, O
Teronen, P Heikkila, H Tschesche, J Leinonen, S Osman and UH Stenman (1997).
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol
Chem. 272(34):21067-21074.
Srinivasan M, AR Sudheer and VP Menon (2007). Ferulic Acid: therapeutic potential through its
antioxidant property. J Clin Biochem Nutr. 40(2):92-100.
LITERATURE CITED
SAIMA, 2017
79
Srivastava KC, RD Austin, D Shrivastava, S Sethupathy and S Rajesh (2012). A case control
study to evaluate oxidative stress in plasma samples of oral malignancy. Contemp Clin
Dent. 3(3):271-276.
Sternlicht MD and Z Werb (2001). How matrix metalloproteinases regulate cell behaviour.
Annual Review of Cell and Developmental Biology. 17:463-516.
Stohs SJ, ZF Al-Bayati, MQ Hassan, WJ Murray and HA Mohammedpeur (1986). Glutathione
peroxidase and reactive oxygen species in TCDD-induced lipid peroxidation. Adv Exp
Med Biol. 197:357-365.
Stoner GD, LS Wang, N Zikri et al. (2007). Cancer prevention with freeze dried berries and
berry components. Semin Cancer Biol. 17(5):403-410.
Su CC, HF Yang, SJ Huang and IB Lian (2007). Distinctive features of oral cancer in Changhua
County: high incidence, buccal mucosa preponderance, and a close relation to betel quid
chewing habit. J Formos Med Assoc. 106:225-33.
Subapriya R, A Thangavelu, B Mathavan, CR Ramchandaran and S Nagini (2007). Assessment
of risk factors for oral squamous cell carcinoma in Chidambaram, Southern India: A
case-control study. Eur J Cancer Prev. 16:251-6.
Subapriya R, R Kumaraguruparan, CR Ramachandran and S Nagini (2002). Oxidant-antioxidant
status in patients with oral squamous cell carcinoma at different intraoral sites. Clin
Biochem. 35(6):489-493.
Sugawara Y, A Uehara, Y Fujimoto, S Kusumoto, K Fukase, K Shibata, S Sugawara, T Sasano
and H Takada (2006). Toll-like receptors, NOD1, and NOD2 in oral epithelial cells. J
Dent Res. 85:524-529.
Sun L, ME Diamond, AJ Ottaviano, MJ Joseph, V Ananthanarayan and HG Munshi (2008).
Transforming growth factor-β1 promotes matrix metalloproteinase-9 mediated oral
cancer invasion through Snail expression. Mol Cancer Res. 6(1):10-20.
Suojanen J, T Salo, E Koivunen, T Sorsa and E Pirila (2009). A novel and selective membrane
type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and
tumor growth. Cancer Biology and Therapy. 8(24):2362-2370.
Suprapaneni KM and GV Raman (2006). Lipid peroxidation and antioxidant status in patients
with carcinoma of prostate. Indian Journal of Physiology and Pharmacology. 50(4):350-
354.
LITERATURE CITED
SAIMA, 2017
80
Sutinen M, T Kainulainen, T Hurskainen, E Vesterlund, JP Alexander, CM Overall, T Sorsa and
T Salo (1998). Expression of matrix metalloproteinases (MMP-1 and -2) and their
inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma
and lymph node metastasis. British journal of Cancer. 77(12):2239-2245.
Tanaka T, M Tanaka and T Tanaka (2011). Oral carcinogenesis and oral cancer
chemoprevention: A review. Pathology Res Int. 2011:1-10.
Thavarajah R, A Rao, U Raman, ST Rajasekaran, ERH Joshua and R Kanan (2006). Oral lesions
of 500 habitual psychoactive substance users in Chennai, India. Arch Oral Biol. 51:512-
9.
Thomas G and V Skrinska (1985). Determination of glutathione in human platelets. Clin Chem.
31:350-351.
Thomas SA and S Sethupathy (2015). Evaluation of oxidative stress in patients with oral
squamous cell carcinoma. Int J Pharm Bio Sci. 6(1B):289-293.
Thrailkill KM, LD Quarles, H Nagase, K Suzuki, DM Serra and JL Fowlkes (1995).
Characterization of insulin-like growth factor-binding protein 5-degrading proteases
produced throughout murine osteoblast differentiation. Endocrinology. 136(8):3527-33.
Tietze F (1969). Enzymic method for quantitative determination of nanogram amounts of total
and oxidized glutathione: applications to mammalian blood and other tissues. Anal
Biochem. 27(3):502-22.
Torri A, Y Kodera, K Uesaka, T Hirai, K Yasui, T Morimoto, Y Yamamura, T Kato, T
Hayakawa, N Fujimoto and T Kito (1997). Plasma concentration of matrix
metalloproteinase 9 in gastric cancer. Br J Surg. 84:133-136.
Tsuda M and Y Ohba (2012). Functional biomarkers of oral cancer. Oral Cancer. 277-294.
Uehara A and H Takada (2008). Synergism between TLRs and NOD1/2 in oral epithelial cells. J
Dent Res. 87:682- 686.
Uehara A, Y Fujimoto, K Fukase and H Takada (2007). Various human epithelial cells express
functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but
not proinflammatory cytokines. Mol Immunol. 44:3100-3111.
Valavanidis A, T Vlachogianni and C Fiotakis (2009). 8-hydroxy-2’-deoxyguanosine (8-OHdG):
A critical biomarker of oxidative stress and carcinogenesis. Journal of environmental
LITERATURE CITED
SAIMA, 2017
81
science and health, Part C: Environmental carcinogenesis and Ecotoxicology reviews.
27(2):120-129.
Van den Steen PE, B Dubois, L Nelissen, PM Rudd, RA Seek and G Opdenakker (2002).
Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9
(MMP-9). Crit Rev Biochem Mol Biol. 37:375-536.
Van Wijk R, EPA Van Wijk, FAC Wiegent and J Ives (2008). Free radicals and low-level
photon emission in human pathogenesis: state of the art. Indian J Exp Biol. 16:273-309.
Vilen ST, P Nyberg, M Hukkanen, M Sutinen, MY Lipalosaari, A Bjartell, A Paju, V
Haaparanta, UH Stenman, T Sorsa and T Salo (2008). Intracellular co-localization of
trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-
9 and enterokinase in carcinoma. Exp Cell Res. 314(4):914-926.
Vilen ST, T Salo, T Sorsa and P Nyberg (2013). Fluctuating roles of matrix metalloproteinase-9
in oral squamous cell carcinoma. Scientific World J. 920595.
Vogl T, K Tenbrock and S Ludwig (2007). Mrp8 and Mrp14 are endogenous activators of Toll-
like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 13:1042-9.
Vu TH, JM Shipley, G Bergers, JE Berger, JA Helms, D Hanahan, SD Shapiro, RM Senior and
Z Werb (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and
apoptosis of hypertrophic chondrocytes. Cell. 93:411-422.
Vurumadla S, KK Akula and V Sangram (2014). A comparative evaluation of enzymatic
antioxidant levels in present and post therapy patients with oral cancer. Int J Pharm
Pharm Sci. 6(11):52-56.
Walsh DM, CH Willams, HE Kennedy, D Allsop and G Murphy (1994). Gelatinase A not alpha-
secretase? Nature. 367(6458):27-8.
Wang H, ER Raybum, W Wang, ER Kandimalla, S Agarwal and R Zhang (2006).
Chemotherapy and chemosensitization of non-small cell lung cancer with a novel
immunomodulatory oligonucleotide targeting Toll-like receptor 9. Mol Cancer Ther.
5:1585-92.
Warnakulasuriya S (2008). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol.
45:309-316.
Warnakulasuriya S (2009). Global epidemiology of oral and oropharyngeal cancer. Oral Oncol.
45(4):309-316.
LITERATURE CITED
SAIMA, 2017
82
Warnakulasuriya S (2014). Prognostic and predictive markers for oral squamous cell carcinoma:
The Importance of clinical, pathological and molecular markers. Saudi Journal of
Medicine and Medical Sciences. 2(1):12-16.
Welgus HG, CJ Fliszar, JL Seltzer, TM Schmid and JJ Jeffrey (1990). Differential susceptibility
of type X collagen to cleavage by two mammalian interstitial collagenases and 72-kDa
type IV collagenase. J. Biol. Chem. 265(23):13521-7.
Westermarck J and V Kahari (1999). Regulation of matrix metalloproteinase expression in tumor
invasion. FASEB J. 13:781-792.
Williams HK (2000). Molecular pathogenesis of oral squamous carcinoma. Mol Pathol. 53:165-
72.
Witko-Sarsat V, M Friedlander, C Capeillere-Blandin, TN Khoa, AT Nguyen, J Zingraff, P
Jungers and B Descamps-Latscha (1996). Advanced oxidation protein products as a
novel of oxidative stress in uremia. Kidney Int. 49:1304-1313.
Wong DT (1993). TGF-alpha and oral carcinogenesis. Eur J Cancer B Oral Oncol. 29(1):3-7.
Wonga T, W Gaob and Z Lib (2014). Matrix metalloproteinase family as molecular biomarkers
in oral squamous cell carcinoma. Biomarkers in cancer. 1-17.
Wu G, YZ Fang, S Yang, JR Lupton and ND Turner (2004). Glutathione metabolism and its
implications for health. J. Nutr. 134(3):489-92.
Wünsch-Filho V (2002). The epidemiology of oral and pharynx cancer in Brazil. Oral Oncol.
38:737-746.
Yadav U and KV Ramana (2013). Regulation of NF-κB-induced inflammatory signaling by lipid
peroxidation-derived aldehydes. Oxid. Med. Cell. Longev. 1-11.
Yang J, EW Lam, HM Hammad, TD Oberley and LW Oberley (2002). Antioxidant enzyme
levels in oral squamous cell carcinoma and normal human oral epithelium. Journal of
oral pathology and medicine. 31(2):71-77.
Ye H, A Wang, B Lee, T Yu, S Sheng, T Peng, S Hu, DL Crowe and X Zhou (2008). Proteomic
based identification of Manganese superoxide dismutase 2 (SOD2) as a metastasis
marker for oral squamous cell carcinoma. Cancer genomics & proteomics. 5:85-94.
Yi-Shing LC and W John (2011). Advances in diagnostic adjuncts for oral squamous cell
carcinoma. The Open Pathology J. 5:3-7.
LITERATURE CITED
SAIMA, 2017
83
Yokoe H, H Nomura, Y Yamano, K Fushimi, Y Sakamoto, K Ogawara, M Shiiba, H Bukawa, K
Uzawa, Y Takiguchi and H Tanzawa (2009). Characterization of intracellular superoxide
dismutase alterations in premalignant and malignant lesions of the oral cavity:
correlation with lymph node metastasis. J Cancer Res Clin Oncol. 135(11):1625-3.
Yorioka CW, RD Coletta, F Alves, IN Nishimoto, LP Kowalski and E Granger (2002). Matrix
metalloproteinase-2 and -9 activities correlate with the disease free survival of oral
squamous cell carcinoma patients. International Journal of Oncology. 20(1):189-194.
Yu BP (1994). Cellular defenses against damage from reactive oxygen species. Physiological
Reviews. 74(1):139-162.
Yu YH, HK Kuo and YL Lai (2007). The association between serum folate levels and
periodontal disease in older adults: data from the National Health and Nutrition
Examination Survey 2001/02. J Am Geriatr Soc. 55(1):108-113.
Zallen G, EE Moore, JL Johnson et al. (1998). New mechanisms by which secretory
phospholipase A2 stimulates neutrophils to provoke the release of cytotoxic agents.
Archives of Surgery. 133(11):1229-1232.
Zhao YG, AZ Xiao, RG Newcomer, HI Park, T Kang, LW Chung, MG Swanson, HE Zhau, J
Kurhanewicz and QX Sang (2003). Activation of pro-gelatinase B by
endometase/matrilysin-2 promotes invasion of human prostate cancer cells. J Biol Chem.
278(17):15056-15064.
Zucker S, RM Lysik, MH Zarrabi and U Moll (1993). M(r) 92,000 type IV collagenase is
increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 53:140-
146.
Zunli K, Y Pan, X Xu, C Nie and Z Zhou (2015). Citrus flavonoids and human cancers. Journal
of food and nutrition resesrch. 3(5):341-351.
Zwetyenga N, C Majoufre-Lefebvre, F Siberchicot, H Demeaux and J Pinsolle (2003).
Squamous cell carcinoma of the tongue: treatment results and prognosis. Rev Stomatol
Chir Maxillofac. 104(1):10-17.
Zygogianni AG, G Kyrgias, P Karakitsos, A Psyrri, J Kouvaris, N Kelekis and V Kouloulias
(2011). Oral squamous cell cancer: early detection and the role of alcohol and smoking.
Head Neck Oncol. 3:2.